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The ability of influenza A virus to cause global pandemics has been a great concern 
throughout history and poses a serious health risk worldwide.  Pandemic outbreaks 
throughout history, such as the Spanish flu of 1918, have claimed the lives of millions of 
people worldwide. The current outbreak of avian influenza (H5N1) that began in 1997 is 
still claiming lives, and therefore efforts to understand the mechanisms of pathogenesis in 
this highly virulent virus are of the utmost importance.  According to the World Health 
Organization, there have been 447 reported H5N1 human cases, resulting in 263 deaths.  
The pathology of H5N1 infection includes pulmonary edema and diarrhea.  Large scale 
sequencing of influenza A viruses revealed that nonstructural protein 1 (NS1) contains a 
class I PDZ motif. The NS1 proteins of avian origin contain the PDZ motif ESEV, which 
has been found to bind several cellular PDZ domain proteins.  The interaction of NS1 and 
host proteins via the PDZ motif is a determinant in the virulence of influenza viruses of 
avian origin.  Consistent with the clinical symptoms, this study is the first to show that 
the NS1 protein of A/chicken/Vietnam/C58/04 binds synapse-associated protein-97 
(SAP-97), an adherens junction protein, in a PDZ motif-dependent manner.  In H5N1 
infected tissues, the SAP-97 distribution is reorganized.  Functionally, the interaction of 
NS1 and SAP-97 results in the loss of epithelial barrier function.  This mechanism helps 
to explain why the two disease states, pulmonary edema and diarrhea, in which epithelial 
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CHAPTER 1. INTRODUCTION 
 
 
1.1   Influenza A Viruses 
 
Influenza A viruses belong to the family Orthomyxoviridae.  The viruses in this 
family are defined by their RNA genome, which is negative-sense (complementary to the 
mRNA sense), single stranded, and segmented [1].  There are three genera, or types, of 
influenza viruses:  A, B, and C.  Influenza A and B viruses have 8 gene segments, while 
influenza C has 7 gene segments. The 8 viral gene segments of influenza A encode 11 
gene products.  These include the PB1, PB1-F2, PB2, PA, HA, NP, NA, M1, M2, NS1, 
and NS2 proteins.  
 
 
1.1.1 The Proteins of Influenza A Virus 
 
PB1, PB2, and PA are the influenza polymerase proteins.  PB2 polymerase is 
encoded by the largest RNA segment (segment 1), while PA is encoded by segment 3.  
PB1 and PB1-F2 are encoded by segment 2.  Together, the polymerase proteins form a 
complex necessary for viral RNA-dependent RNA polymerase activity [1,2].  PB1-F2 
protein is only about 90 amino acids long and is encoded by the +1 reading frame of the 
PB1 gene segment [3,4].  PB1-F2 has been implicated in contributing to viral 
pathogenesis in certain influenza strains.  
 
The nucleoprotein (NP) is encoded by viral RNA segment 5.  NP plays a major role 
in binding and encapsidating the viral RNA to form ribonucleoprotein (RNP).  NP is one 
of the most abundant proteins in the virion and in infected cells [1].   
 
The matrix protein (M1) and the ion channel M2 are both encoded from RNA 
segment 7.  Matrix is the most abundant protein in the influenza virion and is also the 
most highly conserved protein of all the influenza A proteins [2,5].  M1 binds RNP to 
shut off transcription.  M2 protein is an ion channel that is inserted into the virus 
membrane.  The main function of M2 is to transport protons into the virion during 
uncoating.  M2 forms a tetramer, and on the surface of the infected cell it is found in 
large amounts, but is found in smaller amounts on the virion [2].   
 
The nonstructural proteins, NS1 and NS2, are encoded by the smallest RNA 
segment, segment 8.  NS1 protein is produced from the unspliced RNA, while NS2 is 
produced from spliced RNA.  Due to an overlapping reading frame, these 2 proteins have 
the same 9 amino acids at their amino termini.  These proteins were originally named 
nonstructural because they were both thought to be abundantly synthesized in the infected 
cell but not incorporated into virions.  However, it has been found that NS2 binds to M1 
and is incorporated into virions [5].  NS2 contains a nuclear export signal and plays a role 
in nucleo-cytoplasmic export of RNP.  Therefore, it is also known as the nuclear export 
protein (NEP) [6].  NS1 has been detected in cells only after active infection.  The 
multifunctional protein NS1 will be discussed in greater detail below.  
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Hemagglutinin (HA) is encoded by RNA segment 4.  The hemagglutinin protein is a 
membrane protein that is necessary for binding the virion to the receptor on the host cell.  
The HA protein undergoes posttranslational modification, such as glycosylation, 
acylation, and proteolytic cleavage.  HA is cleaved into 2 subunits by host-produced 
proteases.  This cleavage by host proteases is essential for infectivity.  HA also forms the 
major surface antigen and is the main target of the host immune response [1,5].  
 
The neuraminidase (NA) protein is encoded by RNA segment 6.  Like HA, it is an 
integral membrane glycoprotein and is also a major surface antigen.  The main function 
of NA is to cleave terminal sialic acid residues from glycoproteins.  This enables nascent 
virions to free themselves from the host cell receptors of the infected cells from which 
they arose [2]. 
 
Influenza viruses have a standardized naming system and are named according to 
genus, animal species the virus was isolated from, geographical location, isolate number, 
and year.  Influenza A viruses are further classified by hemagglutinin (H) and 
neuraminidase (N) antigenic subtypes.  Of these subtypes, there are 16 distinct 
hemagglutinin antigens (H1-H16) and 9 distinct neuramidase antigens (N1-N9) [7].  
According to the conventional naming scheme, the virus, A/chicken/Vietnam/C58/04 
(H5N1), is of influenza type A and was isolated from a chicken in Vietnam in 2004.   
 
 
1.1.2 Disease Symptoms of Influenza Virus Infection 
 
Influenza A virus infection in humans is highly contagious and causes a respiratory 
disease commonly referred to as the flu.  Symptoms include high fever, inflammation of 
the trachea and upper respiratory tree, coryza, headache, and malaise.  Symptoms often 
linger for 7 to 10 days [8].  Influenza B and influenza C viruses also cause respiratory 
disease in humans.  Influenza B viruses have caused local epidemics, but the number of 
hospital admissions is far less than seen with influenza A viruses [1,9].  Influenza C virus 
causes less severe disease than the other influenza types because most individuals have 
developed antibodies against influenza C by early adulthood [1,10]. 
 
Although influenza B and C cause disease in humans, unlike influenza A virus, they 
do not have the ability to cause global pandemics.  There are two main reasons influenza 
A viruses are able to cause global pandemics while influenza B and C are not.  The first 
main reason for this is the ability of influenza A virus to escape neutralizing antibodies 
through antigenic drift and shift.  The second main factor is that  influenza A virus has a 
wide species tropism [10].  Influenza B and C viruses mainly infect humans, although 
influenza B virus has been recovered from seals, and influenza C virus has been 
recovered from pigs [11,12].  Influenza A viruses on the other hand, infect a wide variety 
of animal species, including humans, swine, horses, dogs, cats, sea mammals, and, most 
importantly, birds [1,2].  Aquatic birds are thought to be the primary reservoir for all 
influenza A viruses which can be thought of as an avian virus that infects many other 
species [2].  Influenza B and C viruses, on the other hand, have not been recovered from 
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avian hosts [2].  Of the 16 hemagglutinin and 9 neuraminidase subtypes, only a few 
combinations of these have been recovered from humans, while all combinations of the 
subtypes are found in birds [2]. 
 
 
1.1.3  Antigenic Shift and Antigenic Drift 
 
One remarkable feature of influenza viruses are their ability to generate new 
antigenic variants that evade host immunity causing annual epidemics and worldwide 
pandemics.  The processes that make this happen are antigenic drift and antigenic shift.  
Antigenic drift results from the accumulation of point mutations during viral replication.  
Point mutations accumulate because the influenza RNA polymerase complex does not 
have any proofreading activity.  The mutation rates are extremely high, and have been 
observed to be greater than 10-3 substitutions per site per year [13].  There is little 
difference between the mutation rates of avian influenza viruses and mammalian 
influenza viruses [13].  A host can develop immunity to influenza virus by developing 
antibodies to the HA and NA proteins.  Antigenic drift gives the virus an advantage by 
changing the surface epitopes, allowing the virus to evade the preexisting protective 
immune response of the host.  Further, certain regions of the surface proteins, such as 
antibody binding sites, are more susceptible to accumulating mutations than other sites of 
the same protein [14]. 
 
The process of antigenic shift is only seen in influenza A viruses.  Antigenic shift is 
the process by which the virus obtains new gene segments by reassortment of two or 
more different subtypes of influenza viruses [15].  This occurs when more than one 
influenza virus isolates infect the same host cell.  Antigenic shift results in a virus with a 
completely different antigenic structure that has not been seen to circulate in the 




1.1.4  H5N1 
 
In 1997, a highly pathogenic influenza virus causing severe respiratory disease 
resulted in the death of a small child in Hong Kong.  Earlier that year, three Hong Kong 
chicken farms reported a highly lethal epidemic of avian influenza.  It was subsequently 
found that a subtype of influenza A virus, H5N1, was responsible for  both the human 
and chicken deaths [16].  Efforts to control this outbreak were quickly undertaken, but 
despite increased supervision of poultry farms more human cases of H5N1 began to 
appear.  Therefore, in December 1997 the Hong Kong government decided to cull all the 
chickens in Hong Kong [16]. With the culling of the chickens, the H5N1 outbreak was 
brought under control.  In total, the 1997 H5N1 outbreak in Hong Kong infected 18 
people and resulted in 6 deaths. This outbreak of H5N1 was distinctive in that the virus 
was transmitted directly from chickens to humans without first infecting an intermediate 
mammalian host [17,18].  Most of the H5N1 patients had close contact with dead or sick 
birds prior the onset of illness [19].  
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In 2003, a resurgence of H5N1 virus caused an epidemic in domestic poultry that has 
spread from Asia to Europe. Human cases of H5N1 also re-emerged in 2003, and new 
cases of human H5N1 infection are being reported to the World Health Organization 
(WHO) to date.  Of the confirmed human cases reported to WHO, H5N1 claimed the 
lives of about 60% of those infected [20]. 
 
In humans, the incubation period of H5N1 is typically between 2 and 5 days, and the 
duration from the onset of symptoms to death is about 9 days [19].  Clinical features of 
the H5N1 virus in human infection vary from individual to individual.  They include 
respiratory symptoms, high fever, malaise, cough, sore throat, and diarrhea as well as 
acute respiratory distress syndrome (ARDS) and multi-organ dysfunction syndrome 
(MODS) [19,21,22]. H5N1 infection differs from seasonal influenza in that 
gastrointestinal symptoms are a common early clinical feature, including abdominal pain, 
vomiting, and watery diarrhea [19].  A large number of H5N1 patients present with 
diarrhea.  In fact, one retrospective report documenting the clinical features of H5N1 in 
Vietnam found that diarrhea was more common in fatal than nonfatal H5N1 cases [23].   
 
Autopsies of H5N1 victims have revealed diffuse alveolar damage, edema, fibrous 
exudates, hyaline membranes, and hyperplasia of type II pneumocytes in the lungs 
[22,24,25].  Histopathological features in the lungs have included cystically dilated 
airspaces, apoptosis of alveolar epithelial cells, pleuritis, and desquamation of epithelial 
cells into the alveolar spaces [26].  Pathology has also been noted in other organs such as 
the spleen, bone marrow, liver, and lymph nodes [22,24,26].  Our study focuses on the 
clinical features of pulmonary edema and diarrhea and therefore the lung and intestines.  
 
In H5N1 patient tissues, viral antigens and genomic RNA have been found in various 
tissues.  Viral antigens and viral RNA have been detected in the respiratory tract.  Among 
cell types found to be positive for viral antigen and sequence are epithelial cells of the 
trachea and type II pneumocytes [26].  Viral RNA has been detected in the brain, and 
viral antigens have been found in neurons [24,25,27].  Further, virus has been isolated 
from cerebrospinal fluid [28]. Viral RNA specific for the HA protein was found in the 
spleen [25]. Viral antigens and viral sequences have been found in both the large and 
small intestine [25,27].  Viral RNA has also been detected in rectal swabs of patients 
[28,29].  One report confirms that H5N1 can replicate in the gastrointestinal tract even in 
patients that don’t experience diarrhea [25].  
 
Attempts to elucidate the molecular mechanisms for viral pathogenesis of H5N1 
have been pursued since the beginning of the outbreak in 1996.  Among the findings are 
the single amino acid change in the RNA polymerase PB2 at position 627 and an amino 
acid change at position 66 of the PB1-F2 protein both of which modulate virulence [30-
32].  The hemagglutinin protein has also been shown to be an important mediator of 
virulence in H5N1 viruses.  Increased cleavability of the receptor by ubiquitous proteases 
has been shown to correlate with increased virulence [30,32]. NS1 has also been reported 
to play a role in the virulence of H5N1.  Single amino acid changes in NS1 at residues 42, 
92, and 149 have been found to increase the virulence of H5N1 [33-35].  Details of the 
H5N1 NS1 studies will be discussed in more detail in the following section. 
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1.2 NS1 Protein  
 
Nonstructural protein 1 (NS1) is encoded by the smallest gene segment (vRNA 
segment 8) of influenza A virus, which encodes both the NS1 and NS2/NEP proteins. 
NS1 is made only during viral infection and has not been found in mature virions. NS1 is 
synthesized during early viral infection, with protein synthesis reaching a peak at 2.5 
hours post infection and remaining high for at least 3 hours after it peaks [36].  NS1 
protein has been shown to have many functions and has been reported to interact with 
various cellular proteins. 
 
 
1.2.1  Structure of NS1 Protein 
 
NS1 has two major domains, the RNA binding domain and the effector domain 
(Figure 1.1).  The RNA binding domain of NS1 encompasses the N-terminal 73 amino 
acids.  The RNA binding domain of NS1 binds double stranded RNA (dsRNA) with very 
low affinity compared to other cellular proteins that are able to bind dsRNA [37,38].  
Structural studies of the RNA binding domain have found that it forms a homodimer in 
solution and is composed of 3 alpha helices [39].  Dimerization of the RNA binding 
domain is critical to its function in binding dsRNA, and each homodimer of NS1 binds 
dsRNA in a 1:1 ratio [38,40].  
 
NS1 proteins from different viruses vary in length of the C-terminus; however, 
amino acid 74 to the C-terminal amino acid makes up the effector domain.  Studies on the 
structure of the effector domain of NS1 have found that, like the RNA binding domain, it 
also forms a homodimer [41,42].  This has been found to be the case for NS1 of both 
human and avian influenza viruses [41,42].  None of the structural studies of the effector 
domain were able to crystallize the last 25 amino acids of the protein.  It is thought that 
the C-terminus of NS1 is highly disordered and only adopts an ordered structure upon 
binding to other proteins [43]. 
 
 
1.2.2  Role of NS1 in mRNA Processing, Translation, and Inhibition of Nuclear Export 
 
NS1 and NS2/NEP are both encoded by vRNA segment 8.  NS1 is encoded by the 
unspliced mRNA, while NS2/NEP is encoded by the spliced transcript.  NS1 has a much 
higher expression level than does NS2/NEP because only about 10% of the viral mRNA 
is spliced [44].  In fact, NS1 inhibits splicing of its own viral pre-mRNA in vitro and in 
vivo [43,45,46]. 
 
NS1 regulates posttranslational processing of RNA polymerase II-driven mRNA 
transcripts.  NS1 inhibits the splicing of mRNA, and it blocks the export of mRNAs that 
contain 3’ poly(A) tails [45].  It was found that both of these functions of NS1 were 
attributable to the effector domain of the protein [47].  Further studies revealed that NS1 
binds the cleavage and polyadenylation specificity factor (CPSF).  CPSF is important in 
pre-mRNA processing and is necessary for cleavage and addition of the poly(A) tail.  By 
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Figure 1.1 Pictorial representation of NS1 protein.   
Pictorial representation of NS1 protein of influenza A/chicken/Vietnam/ C58/04 used 
in these studies.  NS1 protein of this virus contains the PDZ motif ESEV commonly 
found in highly pathogenic H5N1 viruses. 
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binding to CPSF, NS1 prevents the addition of the poly(A) tail and, as a result, mRNAs 
are not exported from the nucleus [48].  Despite this inhibition by NS1, some host pre-
mRNAs in the nucleus are still cleaved and short poly(A) tails are added to them.  NS1 is 
able to block further elongation of these poly(A) tails by targeting the poly(A)-binding 
protein II (PABII) [49].  The binding sites for these protein-protein interactions were 
mapped.  NS1 amino acid residues 180-215 are necessary for binding CPSF.  The 23 C-
terminal amino acids of NS1 are important for binding PABII [50].  During influenza 
virus infection, cellular mRNA and pre-mRNAs trapped in the nucleus are degraded, 
while viral RNA which is selectively exported becomes the predominant mRNA to reach 
the translation machinery [44]. 
 
In addition to targeting proteins involved in processing cellular pre-mRNAs, NS1 is 
able to bind and inhibit proteins that play crucial roles in the mRNA nuclear export.  NS1 
is able to bind p15, NXF1, Rae1, E1B-AP5, and Nup98—all of which form a complex 
and are import protein constituents of the nuclear export machinery [51].  The p15 
protein was found to interact with residues in the effector domain of NS1.  Both RNA 
binding domain and effector domain of NS1 were needed to bind the other proteins in the 
complex [51].   
 
During influenza virus infection there is a global decrease in cellular protein 
expression.  This effect has been attributed to the NS1 protein due to its ability to block 
mRNA processing and nuclear export.  However, NS1’s role in translation has also been 
studied and it has been found that NS1 enhances translation initiation of viral mRNAs 
[52].  It is thought that NS1 is able to enhance translation of viral mRNAs by interacting 
with 5’ extracistronic sequences in the viral mRNA [52].   Another report has shown that 
NS1 can also augment translation of cellular proteins and that this effect was not 
promoter specific [53].  NS1’s ability to enhance translation may be attributed to NS1’s 
ability to block protein kinase R (PKR) activity, as PKR acts to block translation in virus 
infected cells [53].  Further, it was shown that the global shut-off of protein expression 
was not attributable to NS1 as cells infected with an NS1 deficient virus still have a 
global reduction in host protein expression [53]. 
 
 
1.2.3  NS1 Acts to Subvert the Cellular Immune Response  
 
NS1 is a multifunctional protein, and among its many functions, NS1 plays a major 
role in subverting the immune system.  There are many defenses that the infected host 
cell activates upon virus infection.  One early cellular response to viral infection is the 
cellular transcription, activation, and translocation of interferon regulatory factors (IRFs) 
from the cytoplasm to the nucleus [54].  In influenza A virus infection, NS1 counteracts 
this innate immune response by blocking the maturation of mRNAs that encode the IRFs 
[55].  NS1 accomplishes this by inhibiting the 3’ end processing of cellular pre-mRNAs 
by binding to the cleavage and polyadenylation specificity factor (CPSF) and the 
poly(A)-binding protein II (PABII) [37].   
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Another method that host cells use to detect viral replication is through cellular 
proteins that detect dsRNA made during virus infection.  One such pathogen detector, the 
retinoic acid-induced gene I product (RIG-I), is targeted by NS1 [56].  It has been 
proposed that NS1 blocks interferon-β (IFN-β) production through forming a complex 
with RIG-I, although this interaction is not direct [56]. 
 
NS1 is also able to inhibit the activation of protein kinase R (PKR).  PKR is 
activated in infected cells in response to dsRNA.  PKR plays a role in inhibiting viral 
replication by phosphorylating the α-subunit of eIF2, a protein important in translation 
initiation [37].  NS1 interacts directly with PKR, through residues in its effector domain.  
The RNA binding domain of NS1 may also play a role in inhibiting PKR activation; in 
vitro studies have shown the RNA binding domain to be sufficient for inhibition of PKR 
[37].   
 
The NS1 RNA binding domain also functions to subvert the innate immune response 
through another pathway.  2’-5’-oligoadenylate synthetase (OAS) is activated by dsRNA 
made during viral replication.  OAS in turn activates RNase L which degrades RNA, both 
cellular and viral, and therefore inhibits viral replication [57].  NS1 acts to inhibit the 
OAS/RNase L pathway by out competing OAS for binding of dsRNA [58].  Inhibition of 




1.2.4  NS1 and Apoptosis 
 
Differing reports have been published on the role of NS1 in apoptosis.  While some 
studies have reported that NS1 has pro-apoptotic functions, others have reported that NS1 
has anti-apoptotic functions.  One theory that integrates the varying data is that NS1 may 
suppress apoptosis during early viral infection while promoting it during later time points 
of infection. Others maintain that the conflicting data are a result of the different 
experimental procedures, cell types, virus strains, and NS1 constructs used [43].       
 
Two studies have reported that NS1 induces apoptosis in cultured epithelial cells.  
The first study found that RNA binding domain is necessary for the NS1 protein to 
induce apoptosis [59].  The second study reported that NS1 induces apoptosis through the 
death receptor caspase pathway [60].  A number of studies also report that NS1 is anti-
apoptotic [61-64].  These studies also have used various viral constructs and cell types.  
One report concluded that the anti-apoptotic function of NS1 is dependent on its ability to 
block IFN [61].  In human macrophages, it seems that the NS1 protein is working to 
block apoptosis through the inhibition of caspase-1 [62].   
 
Another mechanism by which NS1 may be inhibiting apoptosis is through the 
PI3K/Akt signaling pathway.  The major role of PI3K is to phosphorylate membrane 
phosopholipids, resulting in the generation of phosphatidylinositol-3,4,5-triphosphate 
(PIP3), an important signaling mediator.  PI3K is activated upon binding of its regulatory 
subunit, p85.  Several studies have revealed that NS1 is able to bind and activate 
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phosphatidylinositol-3-kinase (PI3K) by binding the p85β subunit of PI3K [64-67].  NS1 
activation of PI3K is important both for virus replication and inhibition of apoptosis 
through inhibiting the caspase-9 apoptotic pathway [64,65].  
 
 
1.2.5  NS1 of H5N1 
  
Since the beginning of the H5N1 outbreak, efforts have been underway to elucidate 
the molecular mechanisms that contribute to the pathogenicity of this lethal virus.  
Several reports have shown that NS1 plays a role in the virulence of H5N1.  Early studies 
showed that recombinant viruses containing the NS1 of H5N1 had increased 
pathogenesis in pigs.  A single amino acid change at position 92 from aspartic acid to 
glutamic acid was found in the NS1 proteins of these virusesm, and this single amino acid 
change made these viruses more resistant to interferon (IFN) and tumor necrosis factor-α 
(TNF- α) [35].  Further characterization of these viruses in a mouse model found that 
viruses that contained the NS gene of H5N1 induced the production of inflammatory 
cytokines while decreasing the production of anti-inflammatory cytokines [68].   
 
Other studies have uncovered other amino acid residues of NS1 that play a role in 
increasing the pathogenesis of H5N1.  Using recombinant viruses in a mouse model, it 
was found that a single amino acid change at residue 42 also increased virulence of H5N1 
viruses.  A substitution of serine for proline at this position increases virulence by 
antagonizing the induction of IFN though the IRF-3 pathway [34].  
 
By utilizing a chicken model, it was found that amino acid 149 of NS1 also plays a 
role in the virulence of H5N1 viruses.  In this study, only recombinant viruses that 
contain the amino acid alanine at position 149 of NS1 were able to cause disease and 
death in chickens [33].  It was also shown that alanine at position 149 correlates with the 
ability of these viruses to inhibit the IFN response in chicken embryo fibroblasts [33]. 
 
 
1.2.6  The PDZ Motif of NS1 
 
In 2006, a group at St. Jude Children’s Research Hospital (Memphis, TN) undertook 
the task of sequencing 336 avian influenza viruses.  The viruses sequenced in this project 
were collected between 1976 and 2004.  Among the viruses sequenced, all 16 HA and 9 
NA subtypes were represented.  This large-scale sequencing revealed that avian viruses 
have greater sequence variability in their HA, NA, PB1-F2, and NS1 proteins than 
influenza viruses of non-avian origin [69].  This study also identified that the NS1 protein 
of avian influenza A viruses contain a class I PDZ motif.  By assessing the sequences of 
NS1 protein from avian, swine, and human viruses, this study found that a majority of 
NS1 proteins from avian influenza viruses contain the PDZ motif ESEV while the NS1 
proteins of human influenza viruses contain the PDZ motif RSKV.  Further, it was found 
that the highly virulent viruses isolated from the 2003-2004 H5N1 outbreak in Hong 
Kong and Vietnam had the PDZ motif ESEV [69].  Binding studies revealed that NS1 
protein containing the PDZ motif ESEV was able to bind 24 human PDZ proteins while 
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the NS1 protein containing the PDZ motif RSKV was not able to bind these proteins with 
great affinity [69].  The PDZ proteins NS1 was found to bind in this study include 
Partitioning-defective protein 3 (Par3) which plays a role in cell polarity and Lim motif-
containing protein kinase 2 (LIMK2), a protein that plays a role in microtubule 
disassembly [70].  Based on these findings, it was hypothesized that influenza viruses in 
which NS1 contains a PDZ motif of avian origin may interact with host PDZ proteins, 
thus disrupting normal cellular pathways and leading to greater mortality rates [69]. 
 
Further investigation into the role of NS1’s PDZ motif showed that the PDZ motif of 
NS1 plays a role in increasing virulence of influenza viruses.  Using a reverse genetics 
system, several known PDZ motifs of NS1 were incorporated into the NS1 protein of the 
human influenza virus A/WSN/33 [71].  This study showed that influenza viruses, in 
which NS1 contains the PDZ motifs EPEV or ESEV, have increased virulence and 
pathogenicity in infected mouse lungs.  These are the same PDZ motifs found in the 
H5N1 outbreaks in 1997 and 2003, respectively.  The NS1 PDZ motif, KSEV, from the 
1918 H1N1 Spanish flu was also found to increase pathogenicity of the virus in infected 
mouse lungs [71].  Influenza virus in which the NS1 PDZ motif was truncated showed 
less pathogenicity in the infected mice.  This study also investigated whether the 
differences in pathology seen in mouse lungs infected with the recombinant viruses were 
due to an altered ability to circumvent the IFN response; however, it was shown that this 
increased pathogenicity is not caused by changes in the interferon response [71].  
Therefore, it is likely that interactions of NS1 with other host proteins may be responsible 
for the increased virulence seen with influenza viruses that contain a PDZ motif of avian 
origin in the NS1 protein.  
 
 
1.3 PDZ Domains and Motifs 
 
PDZ domains are modular protein-protein interaction domains that were first 
recognized as regions of sequence homology in the 3 proteins postsynaptic density-95 
(PSD-95), discs large (Dlg)—the Drosophilia septate junction protein, and zona 
occludens-1 (ZO-1)—the epithelial tight junction protein.  Therefore the acronym PDZ 
was created.  In the literature, PDZ domains are also referred to as discs large homology 
repeat, or DHR domains, and GLGF repeats for the highly conserved amino acid 
sequence within the domain [72].  PDZ domains are typically about 90 amino acids long 
and show substantial sequence variation.  The significant sequence variation of PDZ 
domains may be what gives these diverse proteins very specific binding capabilities [73].  
The structures of at least 8 PDZ domains have been resolved.  Through these studies, we 
have learned that these domains are compact.  The N- and C-termini of these protein 
domains are brought together in the folded state [72].  PDZ domains fold into six anti-
parallel β-strands that are framed by two α-helices [72,73].  So far, the human genome 
has been found to encode more than 250 PDZ domains in over 100 proteins [74].  PDZ 
proteins assemble together to form supramolecular complexes that function in localized 
signaling and are found in high abundance at points of cell-cell contact [73,75].  PDZ 
proteins are also involved in key processes, such as maintenance of cell polarity and the 
regulation and trafficking of membrane associated proteins [73,75].   
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 While PDZ domains have been found to interact with phospholipids and internal β-
hairpin structures, a majority of PDZ domains mediate interactions with proteins 
containing a sequence-specific carboxy-terminal binding motif (or PDZ motif)[73,76,77].  
There are three classes of PDZ motifs based on the specificity of the ligand.  For class I 
PDZ motifs, this sequence is X-S/T-X-V/L, where X is any amino acid [73].  Class II 
PDZ motifs have the carboxy-terminal consensus sequence X-φ-X-φ, while class III PDZ 
motifs have the consensus sequence X-D-X-V [73].  X represents any amino acid, while 
φ represents a hydrophobic amino acid residue.  PDZ domains preferentially bind C-
terminal peptides through interactions with the highly conserved GLGF motif found in 
PDZ domains.  Protons found in the GLGF motif form hydrogen bonds with the terminal 
carboxylate group of the PDZ motif—thus giving rise to the specificity for C-terminal 
peptides [73].  Different PDZ domains have different stringency requirements for peptide 
binding, giving rise in part to a wide range of binding affinities between PDZ domains 
and their ligands.  Binding affinities measured for PDZ domains and motifs have ranged 
from a Kd of 10-8 M to 10-6 M [73].  Binding affinities in this range are considered 
modest and make PDZ domain/motif interactions ideal for processes that must be 
regulated and reversible [72].  Although much has been uncovered about PDZ domain 
interactions, relatively few proteins have been studied.  Therefore, future studies are 
likely to reveal much more about these physiologically important interactions. 
 
 
1.4 Adherens Junctions 
 
The adherens junction is made up a large protein complex and has many functions, 
including initiating and maintaining cell-cell adhesion, regulating the actin cytoskeleton, 
and intracellular signaling.  Cell-cell adhesion is indispensable to epithelial cell function 
and morphology and is essential in the process of epithelial cell polarization.  Adherens 
junction formation is also crucial for the formation of tight junctions in polarized 
epithelial cells.  The adherens junction initiates cell-cell contact though the binding of E-
cadherin proteins on neighboring cells [78,79].    
 
 
1.5 SAP-97 Protein 
 
Synapse associated protein-97 (SAP-97) belongs to the family of proteins designated 
membrane-associated guanylate kinase (MAGUK).  Each protein in the MAGUK family 
has multiple protein-protein interaction domains, including three PDZ domains, a src 
homology 3 (SH3) domain, and a guanylate kinase (GUK)-like domain (Figure 1.2) 
[80,81].  The guanylate kinase-like domain of SAP-97 is referred to as such because it 
was found that this domain does not actually encode an active guanylate kinase despite 
high sequence similarity to such domains [82].  Each protein in the SAP family is located 
at synapses. SAP-97 is the only protein in the SAP family that is also found in epithelial 
cells, where it localizes to cell-cell junctions [80].  Proteins homologous to SAP-97 have 
been studied in other animal systems.  In Drosophila, this protein is known as the discs 
large (Dlg) tumor suppressor.  In Caenorhabditis elegans, this protein has been 
designated DLG-1, whereas in mammalian cells it is referred to as SAP-97.  SAP-97 is 
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Figure 1.2  Pictorial representation of SAP-97 protein.   
SAP-97 belongs to the MAGUK family of proteins and has three PDZ domains 
(yellow), an SH3 domain (purple), and a GUK-like domain (green).  The above numbers 
correspond to the amino acid residues of the individual PDZ domains. 
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also referred to as human discs large (hDlg) in human systems; however, all these 
proteins are homologous and serve similar functions.  SAP-97 was first cloned and 
characterized in 1994, and it was immediately recognized to bind protein 4.1, a 
cytoskeletal protein that also localizes to adherens junctions [81].  SAP-97 is a 
multifunctional protein. In neurons, SAP-97 interacts with the NMDA receptor and 
inward rectifying potassium channels [80].  SAP-97 also acts as a tumor suppressor in 
some cell types [83]. 
  
 
1.5.1  Tissue Distribution of SAP-97 
 
Mammalian characterization of SAP-97 reveal that SAP-97 mRNA is expressed in 
heart, testis, muscle, liver, and lung tissues of rats [84].  In humans, SAP-97 mRNA or 
protein is detected in heart, muscle, liver, lung, spleen, kidney, brain, and cervical 
epithelia, as well as in T-cells and B-cells [81].  Immunohistological staining of intestinal 
tissues show bright SAP-97 staining in the intestinal villi of rats [84].  In colons of mice 
and human intestine, SAP-97 can be seen at the apical, lateral, and basolateral 
membranes of epithelial cells [85,86].  
 
SAP-97 staining can be seen at points of cell-cell contact in MCF-7 cells, a human 
breast carcinoma cell line [81].  In T84 cells, a human intestinal epithelial cell line, SAP-
97 only localizes to sites of cell-cell contact, and staining is not seen at cell membranes 
that are not in contact with other cells or in isolated cells [84].  In Caco-2 cells, SAP-97 is 
found to localize at the lateral membrane where it co-localizes with E-cadherin [87]. 
 
 
1.5.2  Role of SAP-97 in Adherens Junctions and Cell Polarity 
 
SAP-97 was first studied in Drosophila, where the protein is designated discs large 
(Dlg).  Early work revealed that mutations in Dlg lead to a loss in epithelial cell polarity 
and intercellular adhesion [88].  This loss of cell polarity and cell-cell adhesion leads to 
an overgrowth of the cells of the imaginal discs.  The imaginal discs of the Drosophila 
larvae are the epithelia that give rise to the adult appendages, including the legs, 
antennae, and wings.  A complete loss of Dlg in Drosophila leads to loss of the septate 
junctions in the epithelia of larvae [89].    
 
Work in Caenorhabditis elegans, has shown that DLG-1 is required for the 
formation of adherens junctions [90,91].  DLG-1 is also required for the recruitment of 
other adherens junction proteins, such as AJM-1 and cypin.  In these studies it was noted 
that other apical and basolateral proteins are properly localized even after complete 
knockdown of DLG-1; therefore, it was concluded that DLG-1 plays a major role in the 
establishment and maintenance of adherens junctions but does not play a role in cell 
polarity [90]. 
 
The adherens junction plays a critical role in preserving adhesion between 
neighboring epithelial cells.  SAP-97 has been shown to play critical roles in adherens 
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junction integrity, cell polarity, and epithelial cell differentiation and growth [85,87-
89,92-95].  SAP-97 is recruited to cell-cell adhesion sites in the intestinal epithelial cell 
line Caco-2 [87].  In Caco-2 cells treated with EGTA to remove extracellular calcium, 
SAP-97 distribution moves more intracellularly but remains associated with the actin 
cytoskeleton [87].  In Caco-2 cells grown in low calcium media, SAP-97 staining is seen 
in the cell cytoplasm [87].  It was also noted that E-cadherin mediates the recruitment of 
SAP-97 to sites of cell-cell contact, although it does not bind SAP-97 directly [87].   The 
amino terminal region (first 65 amino acids) of SAP-97 is important in localizing SAP-97 
to the lateral membranes of epithelial cells [96].   
 
Using human derived intestinal epithelial cell lines, it was shown that decreased 
expression of SAP-97 through using RNAi leads to decreased E-cadherin, F-actin and 
phosphatidylinositol 3-kinase (PI3K) at cell-cell contacts [85].  SAP-97 directly interacts 
with the p85 regulatory subunit of PI3K [85].  This finding is of particular significance 
because PI3K recruitment to the primordial adherens junction promotes junctional 
assembly with components of the cytoskeleton, which stabilizes the adherens junction 
and allows for differentiation of enterocytes [97].  Therefore, while in Drosophila, Dlg 
plays a role in both cell polarity and adherens junctions; in mammalian cells and in C. 
elegans, it is thought that this protein plays a major role in adherens junctions and a lesser 
role in cell polarity. 
 
 
1.5.3  SAP-97 Interacts with Other Viral Proteins 
 
Interestingly, SAP-97 has been found to be a target of several viral proteins.  These 
viral proteins bind to SAP-97 through PDZ-motif dependent interactions.  The first virus 
studied was the subgroup D adenovirus type 9.  This virus is able to induce estrogen-
dependent mammary tumors in rats.  The adenovirus type 9 viral protein, designated Ad9 
E4 region ORF 1 protein (9ORF1), is the first viral protein identified to interact with 
SAP-97 [98].  The protein 9ORF1 was found to bind strongly to the second PDZ domain 
of SAP-97, but a weak interaction is also seen with PDZ1 and PDZ3 [98].  This 
interaction was found to be dependent on the PDZ motif of 9ORF1, because proteins that 
contained mutations in this region are not able to bind SAP-97 [98].  Remarkably, viruses 
with mutations in the PDZ motif of 9ORF1 are not able to elicit tumors in rats [98].   
 
Other oncogenic viruses also have proteins that posses a PDZ motif.  Human T cell 
leukemia virus type 1 (HTLV-1) is a retrovirus that causes aggressive and sometimes 
fatal T cell leukemia in adults.  The Tax oncoprotein of HTLV-1 contains the PDZ motif 
ETEV, and has also been found to bind SAP-97 protein in a PDZ-dependent manner 
[98,99].   
 
The human papillomaviruses type 18 and 16 (HPV-18) are associated with genital 
lesions and pose a high risk for cervical cancer.  The E6 oncoprotein of HPV-18, which 
contains the PDZ motif ETQV, binds SAP-97 through PDZ-mediated interactions 
[98,100].  The PDZ motif of HPV-18 is able to bind all three PDZ domains of SAP-97 
[100].  Similarly, the E6 protein of HPV-16 (PDZ motif ETQL) also binds SAP-97 PDZ 
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2 in a PDZ-dependent manner [101].  For HPV-16, ability of the E6 oncoprotein to bind 
SAP-97 correlates with the ability to transform rodent cells [101].  Not only does E6 of 
HPV bind SAP-97, it targets SAP-97 for ubiquitin-mediated degradation [100,102].  
While both E6 of HPV-16 and HPV-18 are able to target SAP-97 for degradation, the 
increased binding affinity of HPV-18 E6 correlates with an increased level of degradation 
of SAP-97 both in vitro and in vivo [102].  In immortalized human epidermal 
keritinocytes, cells expressing E6 have a lower tendency to associate with neighboring 
cells and had a loss of integrity of their adherens junctions [103].     
 
 
1.6 Scope and Objective of Dissertation 
 
The objective of this dissertation project was to investigate the PDZ motif-mediated 
interactions of NS1 with host cell proteins and to determine if these interactions act to 
modulate the pathogenicity of H5N1 influenza viruses.  In this study, I demonstrate that 
NS1 interacts with a host protein, SAP-97, through the PDZ motif.  The data shed light 
into the differences in pathology caused by H5N1 in the presence and absence of the NS1 
PDZ motif.  This study is the first to show that NS1 can interact with SAP-97, an 
important adherens junction protein, and that the NS1 and SAP-97 interaction has a 
functional consequence in disrupting epithelial barrier integrity.
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Human H5N1 infection is characterized by severe respiratory symptoms, including 
pulmonary edema as well as severe diarrhea [21,23].  Both of these disease states result 
from a breakdown in epithelial barrier function and are not common in seasonal influenza 
outbreaks.  Therefore, it was of interest to investigate whether the PDZ motif of NS1 
(found in influenza viruses of avian origin) has a role in disrupting the structural integrity 
of the epithelial barrier.  We sought to identify PDZ proteins important in junctional 
formation that may be interacting with NS1.  For this study, NS1 protein of 
A/Chicken/Vietnam/C58/04 containing the PDZ motif ESEV (NS1-WT) was used.  
Constructs containing mutations in the PDZ motif were also generated.  The construct 
NS1-HuPDZ contains the PDZ binding motif RSKV found in the NS1 protein of 
influenza A viruses of human origin [69], and NS1-ΔPDZ (stop codon at amino acid 223) 
contains no PDZ binding motif.  Several key tight junction and adherens junction proteins 
were tested for their ability to bind NS1.  Proteins examined all contained multiple PDZ 
domains.  We found that the tight junction protein ZO-1 was not able to bind NS1, 




2.2 Materials and Methods 
 
 
2.2.1  Plasmid Construction 
 
We obtained from the lab of Dr. Richard Webby, the p5H58-NS construct that 
encodes NS1 of influenza A/chicken/Vietnam/C58/04.  The p5H58-NS plasmid was used 
as a template to create the pTriEx-4-NS1-WT, pTriEX-4-NS1-HuPDZ, and pTriEx-NS1-
ΔPDZ constructs by ligation independent cloning (LIC).  The 5’ primer used for all three 
reactions was 5’ GACGACGACAAGATGGATTCCAACACT 3’.  The 3’ primer used 
for creating NS1-WT was 5’ GAGGAGAAGCCCGGTTCAAACTTCTGACTCAAT 3’.  
For NS1-HuPDZ the 3’ primer used was: 5’ 
GAGGAGAAGCCCGGTTCAAACCTTTGATCTAAT 3’.  The reverse primer used to 
create NS1- ΔPDZ was 5’ GAGGAGAAGCCCGGT TCACTCAATTGTTCTCGC 3’.  
NS1 was amplified using the polymerase chain reaction (PCR).  The PCR conditions 
used were as follows: 2 minute denaturation at 95°C, 30 amplification cycles with an 
annealing temperature of 62°C, and final extension of 72°C for 7 minutes.  PCR products 
were run on a 1% agarose gel to check for proper size (Figure 2.1).  PCR products of the 
correct size were excised from the gel and extracted using the Qiagen gel extraction kit.  
Purified PCR products were treated with T4 DNA polymerase at room temperature for 30 
minutes to create overhangs that are compatible with the vector.  T4 DNA polymerase 
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Figure 2.1 PCR products for cloning pTriEX-NS1 constructs. 
Agarose gel to confirm proper size of PCR products for the cloning of pTriEX NS1-
WT, pTriEX-NS1-HuPDZ, and pTriEX NS1-ΔPDZ. 
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was then heat inactivated by incubation for 20 minutes at 75°C.  Each insert was then 
incubated with pTriEX-4 LIC vector for annealing.  Resulting plasmids were transformed 
using NovaBlue competent E. coli. for DNA expression and Oragami competent E. coli 
for protein expression.  DNA was extracted from select colonies using a Qiagen miniprep 
kit. Clones were screened for proper sequence at the University of Tennessee’s Molecular 
Resource Center using the T7 promoter primer and the TriEXDOWN primer.  The 
pTriEx vector has N-terminal his6 and S tags.  Using the same primers and template, 
NS1-WT, NS1-HuPDZ, and NS1-ΔPDZ were also cloned into the LIC vector pET41.  
The pET41 vector contains N-terminal Glutathione S-transferase (GST), his6, and S tags. 
 
The UniProtKB/Swiss-Prot entry for SAP-97 (Q12959) was used to determine the 
amino acids that encompass the individual PDZ domains.  Of the full length SAP-97 
protein, the sequence for amino acids 224 to 310 was used to create PDZ 1.  Amino acid 
residues of the full length SAP-97 protein used to make PDZ 2 were 319 to 405, and 
amino acids 466 to 546 were used to create SAP-97 PDZ 3.  The individual PDZ domains 
of SAP-97 were cloned into the LIC vector pTriEX-4, which contains an N-terminal his6 
and S tags.  The plasmid pCDNA3 myc-SAP-97 was used as a template for this cloning.  
This plasmid contains the full length human SAP-97 coding sequence with an N-terminal 
myc tag.  The primers used for SAP-97 PDZ 1 were 5’ 
GACGACGACAAGATGGAAATCACACACTTGAAAGGGGA 3’ for the forward 
sequence and 5’ GAGGAGAAGCCCGGTTCACCTTCTTTTTACATACAAGCGTAC 
3’ for the reverse sequence.  The SAP-97 PDZ 2 primers forward and reverse were as 
follows:  5’ GACGACGACAAGATGGAAATAAGCTCATTAAAGGTCCT 3’ and 
GAGGAGAAGCCCGGTTCAGGGTTTTGCCACTTTCAATAAAC 3’.  The forward 
and reverse primers used for SAP-97 PDZ 3 were 5’ 
GACGACGACAAGATGAAAGTTGTTCTTCATCGTGGCTCA 3’ and 
5’GAGGAGAAGCCCGGTTCATCGATATTGTGCAACAATTGTGAC 3’.  The same 
protocol for LIC cloning was used as stated above for pTriEX-NS1 constructs.  
 
SAP-97 PDZ 1, PDZ 2, and PDZ 3 were subsequently cloned into the pGEX-4T-1 
expression vector, which contains a GST tag in frame and upstream of the multiple 
cloning site.  The templates used for cloning were pTriEX-SAP-97 PDZ 1, pTriEX-SAP-
97 PDZ 2, and pTriEX-SAP-97 PDZ 3.  Primers created for cloning the SAP-97 PDZs 
into pGEX-4T-1 contained 5’ EcoRI and 3’ XhoI restriction site.  The sequences for the 
primers used were 5’ GGAATTCGAAATCACACTTGAA 3’ and 5’ 
CGGCTCGAGTCACCTTCTTTTTACATA 3’ for SAP-97 PDZ 1 forward and reverse, 
respectively.  The SAP-97 PDZ 2 primers used were 
5’GGAATTCGAAATAAAGCTCATT 3’ for the forward sequence and 5’ 
CGGCTCGAGTCAGGGTTTTGCCACTTT 3’ for the reverse sequence.  The SAP-97 
PDZ 3 primers were as follows: 5’ GCAATTCAAAGTTGTTCTTCAT 3’ for the 
forward sequence and 5’ CGGCTCGAGTCATCGATATTGTGCAAC 3’ for the reverse 
sequence.  PCR products were generated using the following conditions: 2 minute 
denaturation at 95°C, 30 amplification cycles with an annealing temperature of 55°C, and 
final extension of 72°C for 7 minutes.  A 10 μL sample of the complete PCR reaction was 
run on a 1% agarose gel to verify that the PCR inserts were of the proper size (Figure 
2.2).  The PCR products were then purified using a Qiagen PCR purification kit and 
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Figure 2.2 PCR products for cloning pGEX4T1-SAP-97 PDZ constructs. 
The agarose gel confirms proper size of PCR products for the cloning of pGEX4T1-
SAP-97 PDZ 1, pGEX4T1-SAP-97 PDZ 2, and pGEX4T1-SAP-97 PDZ 3. 
 
    20 
digested with EcoRI and XhoI at 37°C.  The pGEX-4T1 vector was digested with the 
same enzymes.  The digested inserts were purified on a 1% agarose gel and extracted 
using the Qiagen gel extraction kit.  The purified vector and insert were ligated using the 
Takara DNA ligation kit version 1.  Plasmids were transformed using DH5α competent 
E. coli.  Colonies were screened for proper insert by sequencing with the pGEX 5’ and 
pGEX3’ primers.   
 
 
2.2.2  Cell Culture and Transfection 
 
HEK-293 cells were cultured in DMEM-F12 (Gibco) supplemented with 10% serum 
and 1% penicillin-streptomycin.  HEK-293 cells were cultured in a 5% CO2 incubator at 
37°C.  HEK-293 cells were transfected using the following protocol:  Cells were seeded 
on 35 mm tissue culture dishes at 70-80% confluency.  The next day the cells were 
washed with culture media containing no antibiotics, then incubated with 1.5 mL of the 
antibiotic free media.  The transfection mix was set up in two tubes.  The first tube 
contained 200 μL of OptiMEM media and 1μg DNA.  The second tube contained 200 μL 
of OptiMEM media and 2.5 μL of Lipofectamine™ 2000 transfection reagent 
(Invitrogen).  These tubes were mixed gently, then allowed to incubate at room 
temperature for 20 minutes.  Following incubation, the contents of the tube containing the 
transfection reagent was added to the tube containing the DNA mixture.  The tube was 
mixed gently and allowed to incubate at room temperature for 30 minutes.  The 
transfection mixture was then added to the cell culture dishes in a drop wise fashion and 
incubated at 37°C for 24 hours.   
 
 
2.2.3  Pull Down Assay   
 
HEK-293 cells were transfected with pTriEx NS1 constructs using Lipofectamine 
2000 (Invitrogen).  Twenty-four hours post transfection the cells were washed in PBS and 
lysed in lysis buffer (PBS containing 0.2% Triton-X-100 and protease inhibitors 
(aprotinin [1μg/mL], leupeptin [1μg/mL], pepstatin [1μg/mL], and 
phenylmethanesulfonyl fluoride (PMSF) [500 μM])).  Cell lysate was mixed at 4˚C for 15 
minutes then centrifuged (13,000 rpm) for 10 minutes.  S-Protein Agarose beads 
(Novagen, Darmstadt, Germany) were added to the cleared cell lysate and mixed at room 
temperature for 1 hour.  S-Protein agarose beads were centrifuged at 3000 rpm and 
washed 3 times with lysis buffer. Proteins were eluted from S-Protein agarose beads with 
Laemmli sample buffer.  Eluates were separated on a 4-15% gel, transferred to a PVDF 
membrane by Western, and immunoblotted with anti-SAP-97 antibody (Stressgen, Ann 
Arbor, MI).  The image of this Western blot can be seen in Figure 2.3.  
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Figure 2.3 Pulldown of SAP-97 in HEK-293 cells transiently transfected with 
NS1 constructs. 
HEK-293 cells were transiently transfected with pTriEX-NS1 constructs.  NS1 was 
pulled down using S-Protein agarose beads.  Eluted protein was transferred by 
Western Blot and probed with anti-SAP-97 antibody. 
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2.2.4  Pairwise Binding Assay 
 
GST-SAP-97 PDZ proteins were purified from transformed DH5α E. coli bacteria.  
Protein expression was induced using isopropyl β-D thiogalactopyranoside (IPTG) (200 
μM final concentration).  Bacteria were pelleted by centrifugation at 4000 rpm for 30  
minutes.  Bacterial pellets were frozen at -80°C.  Bacterial pellets were resuspended in 
lysis buffer (50 mM Tris base, 1 mM EDTA, and  10% sucrose) supplemented with 
protease inhibitors (aprotinin [1μg/mL], leupeptin [1μg/mL], pepstatin [1μg/mL], and 
PMSF [500 μM]).  Lysozyme (1mg/mL final concentration) was added to the 
resuspended bacteria and allowed to mix at 4°C for 30 minutes.  Subsequently, 10% 
NP40 (20μL/mL) was added to the suspension and allowed to mix at 4°C for 30 minutes.  
The suspension was then cleared by centrifugation at 20,000 rpm for 30 minutes at 4°C.  
Glutathione beads (50% slurry) were then added to the cleared supernatant and allowed 
to mix for 2 hours at 4°C.  Glutathione beads were retrieved by centrifugation at 3,000 
rpm and washed with 0.2% Triton-X-100 in PBS 3 times, followed by a wash with PBS 
plus protease inhibitors.  A 20 μL sample of the protein bound to the glutathione beads 
were eluted using Laemmli sample buffer and run on a 4-15% gel to visualize the 
quantity and quality of the purified protein (Figure 2.4).  Proteins were eluted from the 
glutathione beads using 10 mM glutathione (pH 7.5).  Glutathione was subsequently 
dialyzed away from the proteins using 3 changes of PBS.  The concentration of purified 
proteins was estimated using the Bradford protein estimation assay.  
 
His-S-NS1 proteins were purified using a similar protocol, with a few notable 
exceptions.  Bacterial pellets were resuspended in resuspension buffer (25 mM HEPES 
and 400 mM potassium chloride (KCl)).  The pH of the resuspension buffer was adjusted 
to 7.4 using potassium hydroxide (KOH).  Just before use, 5 mM beta-mercaptoethanol 
(βME) was added to the resuspension buffer (final concentration of 0.39 μL/mL).  Triton-
X-100 was added to bacterial pellet (final concentration 2.1%) instead of NP40.  Talon 
beads (50% slurry) were added to the cleared supernatant and allowed to mix at 4°C for 
30 minutes.  Recovered Talon beads were washed one time in 0.2% Triton-X-100 in 
PBS, then 4 times in PBS supplemented with protease inhibitors (aprotinin [1μg/mL], 
leupeptin [1μg/mL], pepstatin [1μg/mL], and PMSF [500 μM]).  A 20 μL sample of the 
proteins bound to the Talon beads were eluted using 1 M imidazole, blotted onto a 
nitrocellulose membrane and probed with S-HRP antibody to visualize the quantity of the 
purified protein (Figure 2.5).  Proteins were eluted from the Talon beads using 0.1M 
imidazole.  The concentrations of purified proteins were estimated using the Bradford 
protein estimation assay. 
 
Purified GST-SAP-97 PDZ proteins (2 μg) were incubated with 200 ng of purified 
His-S-NS1-WT protein for 1 hour at room temperature.  Glutathione-Sepharose beads 
(Thermo Scientific) were then added and allowed to mix for an additional hour.  
Glutathione beads were spun down, washed 3 times with lysis buffer, and protein was 
eluted using Laemmli sample buffer.  The resulting protein eluate was separated in 4-
15% SDS-PAGE, transferred to a PVDF membrane, and immunoblotted for NS1 using S-
HRP (Figure 2.6). 
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Figure 2.4. Purified GST-SAP-97 PDZ Proteins. 
The individual PDZ domains of SAP-97 were cloned into pGEX4T1.  Protein was 
expressed in E. coli and purified.   
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Figure 2.5. Purified His-S-NS1 Proteins. 
The NS1 constructs were cloned into pTriEX4.  Protein was expressed in Oragami E. 
coli and purified.   
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Figure 2.6. Pairwise binding of NS1 and individual PDZ domains of SAP-97. 
The purified His-S-NS1-WT protein and the purified individual PDZ domain proteins 
of SAP-97 were incubated together in a pairwise binding assay.   
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2.2.5  Alpha Screen Assay 
 
AlphaScreenTM  association assay for interaction between biotin-NS1-WT (biotin-K-
M-A-R-T-I-E-S-E-V) peptide and GST SAP-97 PDZs proteins (PDZ 1, PDZ 2 and PDZ 
3) was performed using an AlphaScreen Glutathione-S-Transferase (GST) detection kit 
(PerkinElmer).  Starting from 100 µM of final concentration, biotin-NS1-WT peptide was 
serially diluted (in 1/2 log dilution series) in assay buffer (25 mM HEPES, 100 mM 
NaCl, 0.1% BSA, 0.05% Tween 20, pH 7.4) containing GST SAP-97 PDZs (100 nM 
final concentration).  The resulting solutions were incubated at room temperature for 30 
minutes.  Each sample solution (15 µL) was transferred to a white OptiPlate™-384 
microplate (PerkinElmer) in triplicates into which anti-GST acceptor beads (5 µL, 20 
µg/mL final concentration) were added and incubated for 30 minutes at room 
temperature.  Streptavidin donor beads (5 µL, 20 µg/mL final concentration) were then 
added and incubated for 1 hour at room temperature.  The plate was read on an 
EnVision™ 2103 ™ Plate Reader (PerkinElmer).  Results of this assay are shown in 
Figure 2.7.   
 
The procedure of AlphaScreen competition assay of NS1-WT (K-M-A-R-T-I-E-S-E-
V), NS1-HuPDZ (K-M-A-R-T-I-R-S-K-V) or NS1-ΔPDZ (Q-K-R-K-M-A-R-T-I-E) 
peptide against biotin-NS1-WT peptide binding to GST SAP-97 PDZ 2 protein was 
similar to the above described AlphaScreen association assay except that NS1-WT, NS1-
HuPDZ or NS1-ΔPDZ peptides (final concentrations from 1 mM to 3nM) were diluted in 
assay buffer (25 mM HEPES, 100 mM NaCl, 0.1% BSA, 0.05% Tween 20, pH 7.4) 
containing GST SAP-97 PDZ 2 (100 nM final concentration) and biotin-NS1-WT peptide 
(100 nM final concentration).  After the addition of Streptavidin donor beads, the plate 
was incubated for 4 hours at room temperature prior to reading.  The results of this assay 
are shown in Figure 2.8.   
 
 
2.3 Results and Discussion 
 
We identified that SAP-97, an adherens junction protein with 3 PDZ domains 
(Figure 1.2), can complex with NS1 in pull-down assays using HEK-293 cell lysate. 
NS1-WT protein is able to pull down SAP-97, while NS1-HuPDZ and NS1-ΔPDZ were 
not able to pull down SAP-97 (Figure 2.3), suggesting that the interaction between NS1 
and SAP-97 is PDZ motif-dependent.  Next, I sought to determine if this interaction was 
direct and the minimum domain of SAP-97 required to bind NS1.  To accomplish this, 
each PDZ domain of SAP-97 was individually cloned, protein purified, and incubated 
with NS1-WT in a pairwise binding assay (Figure 2.6) The results show that NS1 binds 
the second PDZ domain of SAP-97 (PDZ 2) but does not bind PDZ 1 or PDZ 3 (Figure 
2.6).  These results are consistent with AlphaScreen analysis, which shows that 
biotinylated NS1-WT peptide binds PDZ 2 of SAP-97 but does not bind PDZ 1 or PDZ 3 
(Figure 2.7).  An AlphaScreen competition assay demonstrated that NS1-HuPDZ and 
NS1-ΔPDZ peptides do not compete with biotinylated NS1-WT in binding PDZ 2 of 
SAP-97 (Figure 2.8).  Using the Alpha Screen assay results, the IC50 of the NS1-WT and 
SAP-97 interaction was calculated to be 1.5 μM.   
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Figure 2.7. Interaction of biotinylated NS1-WT peptide and individual PDZ 
domains of SAP-97 as detected by AlphaScreen. 
The purified His-S-NS1-WT protein and the purified individual PDZ domain proteins of 
SAP-97 were incubated together in an AlphaScreen assay.  The sequence of the NS1-WT 
peptide used is biotin- K-M-A-R-T-I-E-S-E-V. 
    28 
Figure 2.8. AlphaScreen competition assay between NS1 peptide binding to SAP-
97 PDZ 2. 
AlphaScreen competition assay between NS1 peptides against biotinylated NS1-WT 
peptides binding to PDZ 2 of SAP-97.  Sequences for the peptides used were as 
follows: NS1-WT peptide (K-M-A-R-T-I-E-S-E-V); NS1-HuPDZ peptide (K-M-A-R-
T-I-R-S-K-V); NS1-ΔPDZ peptide (Q-K-R-K-M-A-R-T-I-E); DMSO was used as 
solvent to prepare the peptide solutions. 
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CHAPTER 3.  SAP-97 LOCALIZATION IS ALTERED IN NS1 TRANSFECTED 





To investigate whether localization of SAP-97 is altered during H5N1 infection, 
mice were infected with two H5N1 recombinant viruses.  The virus A/Vietnam/1203/04 
was utilized.  This virus has a natural truncation in the NS1 protein and therefore contains 
no PDZ motif and will be referred to as H5N1-NS1-ΔPDZ in this study.  A second virus 
was also utilized for these studies.  The recombinant virus is referred to as H5N1-NS1-
WT. The H5N1-NS1-WT virus has the background of A/Vietnam/1203/04 with the NS 
gene of A/Chicken/Vietnam/C58/04.  The NS1 protein of this recombinant virus contains 
the PDZ motif ESEV, a PDZ motif commonly found in highly pathogenic avian influenza 
viruses.  Balb/c mice were infected intranasally with these H5N1 viruses, and at 6 days 
post infection the mice were sacrificed.  The lungs and intestines were harvested and 
fixed in 10% neutral buffered formalin.  Paraffin embedded mouse lungs and intestines 
were labeled with SAP-97 IgG to study the localization of SAP-97 in these tissues. 
 
 
3.2 Materials and Methods 
 
 
3.2.1  Plasmid Construction 
 
To create the plasmids pcDNA3-CFP-NS1-WT and pcDNA3-CFP-NS1-ΔPDZ, a 
pcDNA3-CFP construct already in use in the Naren lab was utilized.  This plasmid 
contains XhoI and KpnI restriction sites 3’ to the CFP insert.  Primers created for cloning 
NS1 into pcDNA3-CFP contained 5’ XhoI and 3’ KpnI restriction sites.  The same 
forward primer was used for the construction of both plasmids because these two 
constructs only vary in sequence at the 3’ end.  The sequence for the forward primer used 
was as follows: 5’ CCGCTCGAGCAATGGATTCCAACACTGTGTCA 3’.  The 
sequences for the reverse primers used were for NS1-WT ( 5’CGG GGTACC TCA AAC 
TTC TGA CTC AAT TGT 3’) and for NS1-ΔPDZ (5’ CGG GGTACC TCA CTC AAT 
TGT TCT CGC CAT 3’).  The templates used for PCR reactions were pTriEX4-NS1-WT 
and pTriEX4-NS1-ΔPDZ.  PCR products were generated using the following conditions: 
2 minute denaturation at 95°C, 30 amplification cycles with an annealing temperature of 
68°C and final extension of 72°C for 7 minutes.  A 10 μL sample of the complete PCR 
reaction was run on a 1% agarose gel to verify that the PCR inserts were of the proper 
size.  The PCR products were then purified using a Qiagen PCR purification kit and 
digested with XhoI  and KpnI at 37°C.  The pCDNA3-CFP vector was digested with the 
same enzymes.  The digested vector and inserts were purified on a 1% agarose gel and 
extracted using the Qiagen gel extraction kit.  The purified vector and insert were ligated 
using the Takara DNA ligation kit version 1.  Plasmids were transformed using DH5α 
competent E. coli.  Miniprep DNA was purified from colonies and was screened for the 
proper size insert by digesting with XhoI and KpnI (Figure 3.1).  The plasmids were 
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Figure 3.1 Screened colonies of cloning pCDNA3-CFP-NS1-WT and 
pCDNA3-CFP-NS1-ΔPDZ constructs. 
Agarose gel to confirm proper size of inserts in the cloning of pCDNA3-CFP-
NS1-WT and pCDNA3-CFP-NS1-ΔPDZ.  Miniprep DNA from select 
colonies was digested with XhoI and KpnI.  Colonies with proper insert size 
were sent for sequencing at the Molecular Resource Center.   
    31 
confirmed by sequencing at the Molecular Resource Center at The University of 
Tennessee Health Science Center, Memphis, TN with the T7 forward and Sp6 reverse 
primers.   
 
 
3.2.2  Cell Culture and Transfection 
 
Caco-2 cells were grown in DMEM (Gibco) supplemented with 10% FBS.  Cells 
were cultured in a 5% CO2 incubator at 37°C.  Caco-2 cells were transfected using the 
following protocol:  Cells were seeded on glass cover slips placed inside 35 mm tissue 
culture dishes at 70-80% confluency.  The next day the cells were washed with culture 
media containing no antibiotics, then incubated with 1.5 mL of the antibiotic free media.  
The transfection mix was set up in two tubes.  The first tube contained 200 μL of 
OptiMEM® Reduced Serum Media and 1μg DNA.  The second tube contained 200 μL of 
Opti-MEM® Reduced Serum Media and 2.5 μL of Lipofectamine™ 2000 Transfection 
Reagent (Invitrogen).  These tubes were mixed gently, then allowed to incubate at room 
temperature for 20 minutes.  Following incubation, the contents of the tube containing the 
transfection reagent was added to the tube containing the DNA mixture.  The tube was 
mixed gently and allowed to incubate at room temperature for 30 minutes.  The 
transfection mixture was then added to the cell culture dishes in a drop wise fashion and 
incubated at 37°C for 48 hours.   
 
 
3.2.3  Animal Infection 
 
Animal studies were approved by the St. Jude Children’s Research Hospital 
Institutional Animal Use and Care Committee. 
 
Six week old Balb/c mice were infected with 103 EID50 units of influenza virus 
A/Vietnam/1203/04 (H5N1-NS1-ΔPDZ) or with A/Vietnam/1203/04 containing the NS1 
gene of A/Chicken/Vietnam/C58/04 (H5N1-NS1-WT) intranasally.  Day 6 post infection, 
the mice were sedated using avertin and sacrificed.  The lungs and intestines were 
harvested and fixed using 10% neutral buffered formalin for 2 weeks before being 
embedded in paraffin.   
 
 
3.2.4  Tissue Processing 
 
After 2 weeks fixation in 10% neutral buffered formalin, tissues were dehydrated 
through passage of graded alcohol.  During the dehydration process, the tissue was 
treated with each of the flowing agents for 1 hour: 70% ethanol, 80% ethanol, 2 changes 
of 95% ethanol, and 4 changes of 100% ethanol.  After dehydration, the tissue was 
dealcoholized in xylene, and then infiltrated with paraffin.  Four micron sections of the 
tissue were mounted on glass laboratory slides for further evaluation. 
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3.2.5  Fluorescent Immunohistochemistry 
 
Paraffin embedded tissue sections of normal Balb/c mice and H5N1 infected Balb/c 
mice (6 days post infection) were deparaffinized using 3 changes of xylene and 
rehydrated through graded ethanol.  Heat-induced epitope retrieval was performed using 
RTU Rodent Decloaker (Biocare Medical).  Sections were incubated with rabbit anti-
SAP-97 antibody (Santa Cruz, CA) followed by AlexaFluor® 488-conjugated anti-rabbit 
IgG.  The fluorescence was visualized using a Zeiss LSM 5 laser scanning confocal 
microscope, and images were collected using Zeiss LSM 5 Pascal software.   
 
 
3.2.6  Immunofluorescent Staining of Caco-2 Cells 
 
Caco-2 cells were seeded on coverslips at 80% confluence were incubated overnight.  
The following morning, Caco-2 cells were transfected with constructs containing N-
terminal CFP tagged NS1-WT or NS1-ΔPDZ (pcDNA3-CFP-NS1-WT or pcDNA3-CFP-
NS1-ΔPDZ.  Forty-eight hours post transfection, the cells were washed 3 times with PBS 
and fixed using ice cold acetone methanol (1:1).  The cells were rehydrated with 3 
washes of PBS, 10 minutes each, then permeabilized using 0.2% Trition-X-100 in PBS 
for 5 minutes.  Blocking was performed using 4% skim milk in TBST at room 
temperature in a humidifying chamber.  To stain for the SAP-97 protein, cells were 
incubated for 2 hours with mouse anti-SAP-97 antibody (Santa Cruz) at a 1:150 dilution 
in 4% milk.  After 3 washes in PBS, slides were incubated with the secondary anti-mouse 
conjugated AlexaFluor 568 antibody.  The secondary antibody was used at a 1:200 
dilution in 4% milk.  Coverslips were incubated with the secondary antibody for 1 hour at 
room temperature in a humidifying chamber in the dark.  The fluorescence was visualized 
using an Olympus FluoViewTM FV1000 fluorescence microscope.  Images were collected 
at 40X magnification using SlideBook™ 5.0 imaging software.  
 
 
3.3 Results and Discussion 
 
In normal mouse lungs, SAP-97 localizes at lateral membranes of alveolar cells 
(Figure 3.2), whereas in H5N1-NS1-WT-infected lungs, SAP-97 shows an intracellular 
distribution (Figure 3.2).  An increased cellular infiltrate can also been seen in the lungs 
of H5N1-NS1-WT-infected mice (Figure 3.2), which is a consequence of the disrupted 
epithelial barrier.  In the lungs of mice infected with H5N1-NS1-ΔPDZ, SAP-97 can still 
be seen to localize to lateral membranes of alveoli (Figure 3.2), even though other 
pathology, such as dilated airspaces, is present in these tissues.   
 33 
Figure 3.2. SAP-97 staining in normal and H5N1 infected mouse lungs.  
(A) SAP-97 staining in normal mouse lung showing staining localized to the lateral 
membranes of alveolar epithelial cells. (B) Inset of normal mouse lung. (C) SAP-97 
staining in H5N1-NS1-ΔPDZ infected mouse lung, demonstrating that SAP-97 is still 
localized to the lateral membranes of alveolar cells. (D) Inset of H5N1- NS1-ΔPDZ 
infected mouse lung. (E) H5N1-NS1-WT-infected mouse lung, showing diffuse SAP-97 
staining that is not restricted to the lateral membranes. (F) Inset of H5N1-NS1-WT-
infected mouse lung.  All images were collected by confocal microscopy at 40X 
magnification.  
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The intestinal epithelia of H5N1-NS1-WT-infected mice show SAP-97 distribution 
is altered in the tips of the villi compared to uninfected controls (Figure 3.3).  The altered 
SAP-97 distribution can also be seen in the intestines of mice infected with H5N1-NS1-
ΔPDZ but appears rarely when compared to the intestines of mice infected with H5N1-
NS1-WT (Figure 3.3).   
 
In Caco-2 cells, SAP-97 distribution is largely at the lateral membranes at sites of 
cell-cell contact, but when Caco-2 cells are transfected with NS1-WT, SAP-97 staining is 
observed intracellularly and is absent at sites of cell-cell contact (Figure 3.4).   
 
These findings are of significance as they indicate that in H5N1 infected tissues and 
cells expressing NS1-WT the interaction between NS1 and SAP-97 redistributes SAP-97.  
This perturbs the junctional integrity of the epithelia and thus causes pulmonary edema in 
the lung tissue and diarrhea in the intestines. 
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Figure 3.3. SAP-97 staining in proximal small intestine of normal and H5N1 infected 
mice.  
(A) SAP-97 staining in normal mouse intestine. (B) SAP-97 staining in intestine of 
mouse infected with H5N1-NS1-ΔPDZ, showing a re-localization of SAP-97 in a small 
area of epithelial disruption. (C) SAP-97 staining in the intestine of H5N1-NS1-WT-
infected mouse, showing extensive re-localization of SAP-97 and. widespread disruption 
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Figure 3.4. SAP-97 staining in NS1 transfected Caco-2 cells.  
(A) Caco-2 cells transfected with cyan fluorescent protein (CFP) tagged NS1-ΔPDZ and 
immunofluorescently stained with anti-SAP-97 antibody (red).  SAP-97 staining is seen 
at cell-cell junctions. (B) Caco-2 cells transfected with CFP-NS1-WT and 
immunofluorescently stained with anti-SAP-97 antibody (red).  SAP-97 staining is not 
visible at cell-cell junctions in the presence of NS1-WT.  All images were collected by 
fluorescent microscopy at 60X magnification. 
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Given that NS1-WT and SAP-97 are interacting physically, we continued to 
investigate whether the interaction plays a functional role in the assembly of epithelial 
junctions.  To that end, we utilized assays that are commonly used to assess the assembly 
and integrity of epithelial junctions.  These assays are the calcium switch assay and the 
inulin flux assay.  Caco-2 cells were chosen for these studies because they are a well 
characterized human colonic epithelial cell line that has a similar morphology to the 
columnar epithelium of the small intestine [104].  Calu-3 cells were also used in calcium 
switch experiments.  Calu-3 cells are a serosal lung epithelial cell line that form resistant 
monolayers, and it was of interest to see if NS1-WT would act similarly on this cell type.  
Thus, we strived to utilize cell lines that would give us relevant information for the two 
pathological symptoms of H5N1 that we were most interested in, diarrhea and pulmonary 
edema.   
 
 
4.2 Materials and Methods 
 
 
4.2.1  Plasmid Construction 
 
The SAP-97 siRNA (5’-GATATCCAGGAACA-3’) and its control scrambled 
siRNA (5’-CCATAATACCAGGTATAA-3’) were cloned into the pSuper plasmid 
(OligoEngline Corp.) as described previously [105].  These plasmids were a kind gift 
from the lab of Dr. Suleiman Bahouth.  The pTriEX-NS1 constructs were generated, as 
described in Chapter 2. 
 
We obtained, from the lab of Dr. Richard Webby, the pSH1203-NS construct, which 
encodes NS1 of influenza A/Vietnam/1203/04.  This plasmid was used as a template to 
create the pTriEx-4-NS1-VTN and pTriEX-4-NS1-VTN-ESEV constructs by ligation-
independent cloning (LIC).  The 5’ primer used is the same as the one used for pTriEX-
NS1-WT cloning since these two genes are identical at the 5’ end.  The reverse primer 
used to create NS1-VTN was 5’ GAG GAG AAG CCC GGT TCA CCG TTT CTG ATT 
TGG AGG G 3’.  The reverse primer used to create NS1-VTN-ESEV was 5’ GAG GAG 
AAG CCC GGT TCA CAC CTC TCA TTC CCG TTT CTG ATT TGG AGG 3’.  NS1-VTN 
and NS1-VTN-ESEV were amplified using the polymerase chain reaction (PCR).  The 
PCR conditions used were as follows: 2 minute denaturation at 95°C, 30 amplification 
cycles with an annealing temperature of 62°C, and final extension of 72°C for 7 minutes.  
PCR products were run on a 1% agarose gel (Figure 4.1).  PCR products of the correct 
size were excised from the gel and extracted using QIAquick Gel Extraction Kit (Qiagen) 
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Figure 4.1 PCR products for cloning pTriEX-NS1-VTN constructs. 
Agarose gel to confirm proper size of PCR products for the cloning of 
pTriEX-NS1-VTN and pTriEX-NS1-VTN-ESEV. 
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gel extraction kit.  Purified PCR products were treated with T4 DNA polymerase at room 
temperature for 30 minutes to create overhangs that are compatible with the vector.  T4 
DNA polymerase was then heat inactivated by incubation for 20 minutes at 75°C.  Each 
insert was then incubated with pTriEX-4 Ek/LIC vector for annealing.  Resulting 
plasmids were transformed using NovaBlue competent E.coli. for DNA expression.  
DNA was extracted from select colonies using a Qiagen miniprep kit.  Clones were 
screened for proper sequence at The University of Tennessee Health Science Center’s 
Molecular Resource Center using the T7 promoter primer and the TriEx-DOWN primer.  
The pTriEx vector has N-terminal his6 and S tags.   
 
 
4.2.2  Cell Culture and Transfection 
 
Caco-2 cells were grown in DMEM (Gibco) supplemented with 10% FBS.  Cells 
were cultured in a 5% CO2 incubator at 37°C.  Calu-3 cells were grown in MEM (Gibco) 
supplemented with 10% FBS and 1% each of sodium pyruvate and non-essential amino 
acids. 
 
Caco-2 cells were transfected using the following protocol:  Cells were seeded in 60 
mm tissue culture dishes at 70-80% confluency.  The next day the cells were washed with 
culture media containing no antibiotics, then incubated with 1.5 mL of the antibiotic free 
media.  The transfection mix was set up in two tubes.  The first tube contained 200 μL of 
OptiMEM media and 1μg DNA.  The second tube contained 200 μL of OptiMEM media 
and 2.5 μL of Lipofectamine™ 2000 transfection reagent (Invitrogen).  These tubes were 
mixed gently then allowed to incubate at room temperature for 20 minutes.  Following 
incubation the contents of the tube containing the transfection reagent is added to the tube 
containing the DNA mixture.  The tube was mixed gently and allowed to incubate at 
room temperature for 30 minutes.  The transfection mixture was then added to the cell 
culture dishes in a drop wise fashion and incubated at 37°C for 24 hours.   
 
Calu-3 cells were transfected using FuGENE® 6 transfection reagent (Roche).  Cells 
were seeded on 60mm tissue culture dishes at 50-60% confluence.  The next day, cells 
were rinsed two times with serum free media, then incubated with serum free media with 
no antibiotics for 30 minutes.  To set up transfection, 6 μL of FuGENE 6 was added to 94 
μL of serum free media, mixed and allowed to incubate for five minutes.  After the five 
minute incubation, 1 μg of DNA was added to the transfection mix and incubated for 20 
minutes.  The transfection mix was then added to the cells in a drop wise fashion and 
allowed to incubate at 37°C for 24 hours. 
 
 
4.2.3  Measurements of TER, Calcium Switch Assays and Inulin Flux Assay 
 
Caco-2 cells were transiently transfected with NS1 constructs, SAP-97 siRNA, or 
scrambled siRNA using Lipofectamine 2000 (Invitrogen).  Twenty-four hours post 
transfection, Caco-2 cells were trypsinized, counted and seeded on 12mm polycarbonate 
membranes in transwells (Costar) at 2x105 cells/membrane.  Calcium switch assays 
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performed on Caco-2 cells were done as described previously on the fourth or fifth day 
post transfection[106].  On the day of the calcium switch, cells were serum starved for 
one hour using glutamine free DMEM.  After serum starvation, baseline transepithelial 
electrical resistance (TER) measurements were recorded.  Caco-2 cells were treated with 
4 mM ethyleneglyol-bis(2-aminoethylether)N,N,N′,N′, tetraactetic acid (EGTA) in 
DMEM (pH 7.35) in both the apical and basolateral wells to reduce the transepithelial 
electrical resistance.  Cells were then washed 3 times with DMEM to remove EGTA.  
TER was measured at regular intervals after EGTA was removed to monitor 
reestablishment of cell junctions.  TER was measured using a electric voltometer 
purchased from World Precision Instruments. 
 
Calcium switch assays performed in Calu-3 cells were performed using a different 
strategy than was used with Caco-2 cells.  Calu-3 cells were transfected with NS1 
constructs using FuGENE 6 (Roche).  Twenty-four hours post transfection, cells were 
seeded on 6.5 mm transwells (Costar) at 7.2x104 cells/membrane in low calcium media 
(0.5 mM CaCl2, 5% dialyzed FBS, 200 mM L-glutamine, 1% sodium pyruvate, and 1% 
penicillin in calcium free DMEM).  Twenty-four hours post seed the cells were washed 
four times with glutamine free MEM and baseline TER was recorded.  After cells were 
switched to normal growth media, TER was recorded at 30 min intervals.  
  
Inulin flux assays in Caco-2 cells were performed as described previously on the 
fourth or fifth day post transfection [106].  After the calcium switch, cells were incubated 
with 0.5 mg/mL fluorescein isothiocyanate-inulin (FITC-inulin) in the basal well.  At 
various time points 100 ul of media was withdrawn from both the basal and apical wells 
and fluorescence was measured using a fluorescence plate reader (BioTEK Instruments).  
The excitation of FITC inulin is 488 nm and emission was read at 505 nm.  Flux into the 
apical well was calculated as percentage of the total fluorescence of the basal well/hr/cm2 
of the surface area. 
 
Statistical analyses were done using Student’s t-test (homoscedastic, 2-tailed).  A p 
value of <0.05 was considered significant.  All the results are represented as mean ± 
standard error mean.   
 
 
4.3 Results and Discussion 
 
First, we transfected Caco-2 cells with SAP-97 siRNA or scrambled siRNA to 
validate the role of SAP-97 in maintaining adherens junction integrity.  Briefly, 
transfected cells were plated on transwell inserts, and after they had formed resistant 
monolayers, they were treated with EGTA to disrupt cell-cell contacts and monitored for 
reestablishment of cell junctions using trans-epithelial resistance (TER) measurements.  
As shown in Figure 4.2, in cells transfected with SAP-97 siRNA, junctional formation 
was impaired compared to scrambled siRNA transfected cells, as indicated by low TER 
values for SAP-97 siRNA transfected cells.  This result is consistent with a previous 
report that SAP-97 plays a critical role in cell junction formation as measured by TER 
[107].  Next, we transfected Caco-2 cells with NS1-WT and monitored reestablishment of 
    44 
Figure 4.2 NS1 and SAP-97 siRNA disrupt junctional integrity in transfected 
Caco-2 cells.  
Transepithelial electrical resistance (TER) measurements in transfected Caco-2 cells 
at 90 minutes post calcium switch.  Cells were transfected with empty vector 
(Vector), pTriEX-NS1-WT (NS1-WT), pSuper -scrambled siRNA (Scrambled) or 
pSuper-SAP-97 siRNA (SAP-97 siRNA).  Figure is representative of three separate 
experiments. n=3 for each experiment.  *p<0.05 
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TER after calcium switch. The result clearly shows that junctional assembly of NS1-WT 
transfected cells are impaired compared to vector transfected cells; however, cells 
transfected with NS1-HuPDZ or NS1-ΔPDZ are not impaired in reestablishing cell-cell-
junctions (Figure 4.2 and Figure 4.3).   
 
A similar trend was observed in polarized Calu-3 cells transfected with NS1-WT 
(Figure 4.4).  Notably, the TER of Calu-3 cells transfected with NS1-ΔPDZ is similar to 
vector transfected cells (Figure 4.4).  This result indicates that the PDZ motif-dependent 
interaction between NS1-WT and SAP-97 disrupts the assembly of epithelial junctions.   
 
This hypothesis was further supported by results of inulin flux assays in which Caco-
2 cells were transfected with NS1-WT.  The inulin flux assay measures the ability of a 
large molecule (inulin Mr ≈ 5000) to move from the basolateral to apical side of the cell 
monolayer.  Due to its large size, inulin will only be able to move across the epithelial 
cell monolayer if the barrier is compromised.  As can be seen in Figure 4.5, NS1-WT 
transfected cells demonstrate higher rates of inulin flux compared to cells transfected 
with vector, indicating that juctional integrity is impaired in these cells (Figure 4.5).  
However, Caco-2 cells transfected with NS1-ΔPDZ showed similar inulin flux rates to 
cells transfected with vector.  Taken together, the data indicate that the PDZ motif-
dependent interaction of NS1-WT and SAP-97 disrupts the functional assembly of 
epithelial junctions, a process integral to the integrity of epithelial barriers. 
 
To further examine the importance of the PDZ motif in the disruption of functional 
cell-cell junctions, other NS1 constructs were created from the NS1 gene of the virus 
A/Vietnam/1203/04.  This construct was named NS1-VTN.  The NS1 protein of the 
Vietnam virus has a truncation of the last 10 amino acids and therefore does not contain a 
PDZ motif.  In addition to this early stop codon, the NS1 of the Vietnam virus has 5 
additional amino acid changes when compared to the NS1 protein of 
A/Chicken/Vietnam/C58/04 (NS1-WT).  An additional construct was created in which 
the PDZ motif ESEV was added to the end of the VTN protein.  This construct was 
named NS1-VTN-ESEV.  Both of these constructs were tested in calcium switch assays 
in Caco-2 cells and compared to NS1-WT and NS1-ΔPDZ.  As can be seen in Figure 4.6, 
NS1-VTN, which has no PDZ motif, behaves similarly to NS1-ΔPDZ.  Reestablishment 
of cell junctions is not impaired in the presence of these two proteins (NS1-ΔPDZ and 
NS1-VTN).  However, when the PDZ motif is introduced to the NS1-VTN protein, 
epithelial junction formation is impaired similarly to NS1-WT (Figure 4.6).  This result 
is evidence that the PDZ motif of NS1 plays a critical role in the disruption of the 
epithelial barrier.  Taken together, the data indicate that the PDZ motif-dependent 
interaction of NS1-WT and SAP-97 disrupts the functional assembly of epithelial 
junctions, a process integral to the integrity of epithelial barriers.   
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Figure 4.3 NS1 disrupts junctional integrity in transfected Caco-2 cells.  
Transepithelial electrical resistance (TER) measurements in transfected Caco-2 cells 
after 90 minutes after EGTA disruption of the cell junctions.  NS1-WT (WT) 
transfected cells display much lower TER values than vector transfected controls 
(V).  NS1-HuPDZ (Hu) and NS1-ΔPDZ (Δ) transfected cells are not statistically 
different from vector controls (V).  Figure is representative of two separate 
experiments. n=4 for each experiment. *p<0.05 
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Figure 4.4 NS1 disrupts junctional integrity in transfected Calu-3 cells.  
TER in transfected Calu-3 cells after switch from low calcium media to normal 
growth media. Figure is representative of three separate experiments. n=3 for each 
experiment.  *p<0.05 **p<0.005 
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Figure 4.5 Inulin Flux in NS1 transfected Caco-2 cells.  
Inulin flux measurements in Caco-2 cells transfected with vector (V), NS1-WT (WT), 
or NS1-ΔPDZ (Δ) post calcium switch.  Flux values between vector and NS1-ΔPDZ 
transfected cells are not significant. *p<0.05 
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Figure 4.6 Calcium switch assay in NS1-VTN and NS1-VTN-ESEV transfected 
Caco-2 cells.  
TER measurements in transfected Caco-2 cells after 90 minutes after recovery from 
EGTA disruption of the cell junctions. NS1-ΔPDZ (Δ) and NS1-VTN (VTN) transfected 
cells show little inhibition of recovering cell-cell junctions after treatment, while NS1-
WT (WT) and NS1-VTN-ESEV (V-ESEV) transfected cells are markedly inhibited in 
their ability to establish cell-cell junctions.  Figure is representative of two separate 
experiments. n=4 for each experiment. *p<0.005 
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CHAPTER 5. THE PDZ MOTIF OF NS1 ACTS AS A VIRULENCE FACTOR IN 





The PDZ motif of NS1 has previously been postulated to modulate virulence in 
influenza viruses of avian origin [69,71].  To characterize the pathogenicity of H5N1 
virus containing the PDZ motif in the NS1 protein, the virus A/Vietnam/1203/04 was 
utilized. This virus has a truncated NS1 protein and thus has no PDZ motif and will be 
referred to as H5N1-NS1-ΔPDZ in this study.  Using the same background 
(A/Vietnam/1203/04), a recombinant virus containing the NS gene of 
A/Chicken/Vietnam/C58/04 was engineered.  The NS1 protein of this recombinant virus 
contains the PDZ motif ESEV commonly found in highly pathogenic avian influenza 
viruses.  The recombinant virus was referred to as H5N1-NS1-WT in these studies.   
 
 
5.2 Materials and Methods 
 
 
5.2.1  Animal Studies 
 
Six week old Balb/c mice were infected with 103 units of influenza virus 
A/Vietnam/1203/04 (H5N1-NS1-ΔPDZ) or with A/Vietnam/1203/04 containing the NS1 
gene of A/Chicken/Vietnam/C58/04 (H5N1-NS1-WT) intranasally.  Day 6 post infection, 
the mice were sedated using avertin and sacrificed.  The lungs and intestines were 
harvested and fixed using 10% neutral buffered formalin then embedded in paraffin.  
Paraffin sections were stained with hematoxylin and eosin (H&E) for evaluation.   
 
 
5.2.2  Tissue Processing 
 
After two weeks fixation in 10% neutral buffered formalin, tissues were dehydrated 
through passage of graded alcohol.  During the dehydration process, the tissue was 
treated with each of the flowing agents for 1 hour: 70% ethanol, 80% ethanol, two 
changes of 95% ethanol, and four changes of 100% ethanol.  After dehydration, the tissue 
was cleared in xylene, and then infiltrated with paraffin.  Four micron sections of the 
paraffin embedded tissue were mounted on glass laboratory slides for further evaluation. 
 
A routine hematoxylin and eosin staining procedure was used to stain paraffin 
embedded tissue sections.  First the sections were deparaffinized using three changes of 
xylene at 5 minutes each.  Sections were then rehydrated by passage through graded 
alcohols for 2 minutes each.  These included two changes of 100% ethanol, 95% ethanol, 
and 80% ethanol.  The slides were then rinsed in water.  To stain cell nuclei, slides were 
incubated for 2 minutes in Harris’s hematoxylin solution.  Excess hematoxylin was 
removed by rinsing slides in tap water and decolorized by incubating slides in 0.5% acid 
 51 
alcohol for a few seconds.  Color of hematoxylin was adjusted by incubating slides for 1 
minute in Scott’s Bluing Reagent.  The cytoplasm of cells was counterstained by 
incubating slides with 0.5% alcoholic eosin for 1 minute.  Tissue sections were then 
dehydrated by passage through graded ethanol for 1 minute each (two changes of 95% 
ethanol, and three changes of 100% ethanol).  Tissue sections were then cleared by 
passage through three changes of xylene before being mounted with permanent mounting 
media.    
 
 
5.2.3  Pathology Scoring 
 
Paraffin sections were stained with hematoxylin and eosin for evaluation.  For lung 
pathology scores, each lobe of infected lungs was examined and given severity scores for 
interstitial infiltrate and alveolar infiltrate.  A score of 0 was given to normal tissues.  
Tissues that were mildly affected, moderately affected, or severely affected were given 
scores of 1, 2, and 3, respectively.  
  
Each affected area of intestinal villi in infected mice was viewed at high power 
magnification (40X).  Only affected areas of villi were examined.  The percentages of 
affected villi were counted for each field.  Areas that had 30-45% edematous tissue were 
given a score of 1, while areas with 46-60% edematous tissue, areas with 61-75% 
edematous tissue, and areas with 76-100% edematous tissue were given scores of 2, 3, 
and 4, respectively.  The number of fields counted for mice infected with H5N1-NS1-
ΔPDZ (n=6) was less than those for H5N1-NS1-WT (n=17) due to less of the tissue 
displaying pathology.  Each tissue section was counted only once.   
 
Pathology scores were assigned by a medical pathologist who had no previous 
knowledge of the aims of our study. 
 
 
5.2.4  Immunohistochemical Staining of H5N1 Antigen 
 
Staining for influenza A virus was performed in the same tissues that were stained 
with hematoxylin and eosin for pathologic evaluation.  Paraffin embedded tissue sections 
of normal Balb/c mice, H5N1-NS1-WT, and H5N1-NS1-ΔPDZ infected Balb/c mice (six 
days post infection) were deparaffinized, using three changes of xylene, and rehydrated 
through graded ethanol (two changes of 100% ethanol, 95% ethanol, 70% ethanol, then 
water).  Sections were treated with peroxidized I (Biocare Medical) for 5 minutes to 
reduce background staining by endogenous peroxidases in the tissue.  Heat induced 
epitope retrieval was performed by pressure cooking slides in Borg Decloaker (Biocare 
Medical).  Rodent block M (Biocare Medical) was utilized for the blocking buffer and 
was carried out at room temperature in a dark humidifying chamber.  Sections were 
incubated with antibody against influenza A (US Biological) diluted 1:1000 in DaVinci 
green antibody diluent (Biocare Medical) for 2 hours at room temperature in a dark 
humidifying chamber.  Primary antibody was washed from the slides in 2 changes of 
TBS (tris buffered saline).  The secondary antibody incubation utilized biotin conjugated 
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donkey anti-goat secondary antibody (Santa Cruz) diluted 1:200 in DaVinci green 
antibody diluent.  Vectastain Elite ABC kit (Vector Laboratories) and DAB Chromagen 
Kit (Biocare Medical) were used to visualize the protein.  Slides were counterstained with 
Gill’s Hematoxylin.  Color of hematoxylin was adjusted by incubating slides for 1 minute 
in Scott’s Bluing reagent.  Tissue sections were then dehydrated by passage through 
graded ethanol for 1 minute each (two changes of 95% ethanol, and three changes of 
100% ethanol).  Tissue sections were then cleared by passage through three changes of 
xylene before being mounted with permanent mounting media. 
 
 
5.3 Results and Discussion 
 
To characterize the pathogenicity of H5N1 virus containing the PDZ motif in the 
NS1 protein, the virus A/Vietnam/1203/04 was utilized. This virus, referred to as H5N1-
NS1-ΔPDZ, has a truncated NS1 protein and thus has no PDZ motif.  Using the same 
background (A/Vietnam/1203/04), a recombinant virus containing the NS gene of 
A/Chicken/Vietnam/C58/04 was engineered.  The NS1 protein of this recombinant virus 
contains the PDZ motif ESEV, a PDZ motif commonly found in highly pathogenic avian 
influenza viruses.  The recombinant virus is referred to as H5N1-NS1-WT in these 
studies.  Balb/c mice were infected intranasally.  At 6 days post infection, the mice were 
sacrificed and the lung and intestines were harvested for histological analysis.   
 
Hematoxylin and eosin staining of the tissues revealed multi-focal lesions and 
pulmonary edema in H5N1-NS1-WT-infected lungs (Figure 5.1).  Severe alveolitis, 
primary viral pneumonia, and dilated airspaces were observed in the H5N1-NS1- nfected 
lung tissues (Figure 5.1).  Cellular infiltrate of lung tissues and hemorrhage into 
airspaces were also commonly observed (Figure 5.1).  These disease states are evidence 
that the epithelial barrier function in the lung has been compromised.  To evaluate disease 
pathology, each lobe of the infected lungs was examined and given a score to reflect the 
severity of the interstitial and alveolar infiltrate.  Lungs of mice infected with H5N1-
NS1-WT tended to have higher scores in both the severity of interstitial and alveolar 
infiltrates than lungs of mice infected with H5N1-NS1-ΔPDZ (Figure 5.2).  
Immunohistological staining for the influenza A revealed that virus was present in both 
H5N1-NS1-WT and H5N1-NS1-ΔPDZ lungs (Figure 5.3); therefore, the difference in 
pathology is not due to differences in infectivity of the two viruses.  
 
Pathology in the small intestines of H5N1-NS1-WT-infected mice included edema in 
the tips of the lamina propia. Both intercellular and intracellular edema could be seen at 
the tips of the villi (Figure 5.4).  The small intestines of mice infected with H5N1-NS1-
ΔPDZ were only mildly focally affected (Figure 5.4).  An evaluation of the percentage of 
affected villi in each high powered field revealed that H5N1-NS1-WT-infected intestines 
tended to have greater percentages of affected villi per field (Figure 5.5).   
 
The differences seen in the pathology of tissues of mice infected with the virus 
H5N1-NS1-WT versus tissues of mice infected with H5N1-NS1-ΔPDZ gives clear 
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Figure 5.1 Pathology of H5N1 infection in mouse lungs.   
(A) Uninfected mouse lung. (B) Lung of H5N1-NS1-WT-infected mouse at 6 days 
post infection showing viral pneumonia and pulmonary edema. (C) Lung of H5N1-
NS1-ΔPDZ-infected mouse at 6 days post infection displaying little inflammation. 
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Figure 5.2 Lung pathology scoring of H5N1 infection in mouse lungs.   
(A) Interstitial infiltrate severity scores of H5N1-NS1-WT (n=9) and H5N1-NS1-
ΔPDZ-infected lung lobes (n=7) examined. (B) Alveolar infiltrate severity scores of 
H5N1-NS1-WT (n=9) and H5N1- NS1-ΔPDZ (n=7) lung lobes examined. The first 
two points overlap but have been adjusted in order for both groups to be seen. 
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Figure 5.3 Influenza A antigen staining in H5N1 infected mouse lungs.   
(A) Influenza A antigen (DAB chromagen, brown color) staining in uninfected 
mouse lung. (B) Influenza A antigen staining in H5N1-NS1-WT and (C) H5N1-NS1-
ΔPDZ infected mouse lungs.  Sections were counterstained with hematoxylin. 
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Figure 5.4 Pathology of H5N1 infection in mouse intestines.  
(A) Normal mouse small intestine. (B) Small intestine of H5N1-NS1-WT-infected 
mouse showing intracellular and intercellular edema in the epithelial layer and the 
lamina propia. (C) Small intestine of mouse infected with H5N1-NS1-ΔPDZ 
showing only mild focal edema. (D) Proximal small intestine of H5N1-NS1-WT-
infected mouse in which both crypts and villi can be seen. (E) Proximal small 
intestine of H5N1-NS1-ΔPDZ-infected mouse in which both crypts and villi can be 
seen. 
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Figure 5.5 Pathology scoring of edematous tissue in intestines of mice infected 
with H5N1.  
Edematous intestinal tissue scores of mice infected with H5N1-NS1-WT or H5N1-
NS1-ΔPDZ. 
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evidence that the PDZ motif of NS1 acts as a virulence factor in avian H5N1 influenza 
viruses.   
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CHAPTER 6.  DISCUSSION 
 
 
Clinical features of the H5N1 virus in human infection include respiratory symptoms 
and diarrhea, two disease states in which epithelial barrier function is disrupted [21]. 
Autopsies of H5N1 victims have revealed diffuse alveolar damage, edema, fibrous 
exudates, hyaline membranes, and hyperplasia of type II pneumocytes in the lungs 
[22,24,25].  Pathology has also been noted in other organs such as the spleen, bone 
marrow, and lymph nodes [22,24].  Our study focuses on the clinical features of 
pulmonary edema and diarrhea and therefore the lung and intestines.   
 
The aim of this study was to define how PDZ motif-mediated interactions of NS1 
contribute to the pathogenicity of the virus, particularly in the lung and intestine.  We 
sought to examine whether the disease phenotype was altered in the presence or absence 
of the PDZ motif of NS1.  Balb/c mice infected with H5N1 showed more severe disease 
pathology when infected with H5N1-NS1-WT, a virus that contains the PDZ motif ESEV 
in NS1, as compared to mice infected with H5N1-NS1-ΔPDZ (a virus that has no PDZ 
motif in the NS1 protein).  Pathology findings include primary viral pneumonia, 
pulmonary edema, and alveolitis.  The difference in disease phenotype between H5N1-
NS1-WT- and H5N1-NS1-ΔPDZ-infected mice is best reflected by the disease severity 
scores assigned by a pathologist.  H5N1-NS1-WT-infected lungs tended to receive higher 
scores for interstitial and alveolar infiltrate than did the lungs of mice infected with 
H5N1-NS1-ΔPDZ.  The difference in disease phenotype is not due to a difference in 
infectivity of the two viruses, as evidenced by our observation that antigen staining for 
influenza A virus was robust in both the H5N1-NS1-WT and H5N1- NS1-ΔPDZ mouse 
lungs.  The intestines of H5N1-infected mice also showed differential disease pathology.  
The intestines of mice infected with H5N1-NS1-WT tended to have more edematous villi 
than intestines of mice infected with H5N1-NS1-ΔPDZ.  It is of importance to note that 
the pathologist who analyzed the mouse tissue and assigned pathology scores did so 
without previous knowledge of the aim of our study. 
 
There are five amino acid differences in the NS1 proteins of these two viruses 
(H5N1-NS1-WT and H5N1-NS1-ΔPDZ), in addition to the truncation mutation found in 
NS1 of H5N1-NS1-ΔPDZ.  Further, mutations at the C-terminus of NS1 cause mutations 
in the NS2/NEP protein due to an overlapping reading frame.  The contributions of these 
individual mutations to the overall phenotype seen in the pathology studies cannot be 
ruled out.  However, the differences seen in pathology, taken together with the functional 
studies (Figure 4.6), lead us to conclude that the PDZ-binding ligand of NS1 plays the 
major role in disrupting the epithelial barrier, thus leading to the differences in pathology 
of the two different viruses in the mouse lung and intestine. 
 
Viral antigens and viral RNA have been detected in patient lung, brain, spleen, and 
intestine [24,25,27].  A large number of H5N1 patients present with diarrhea; therefore, it 
was of interest to further investigate mechanisms behind this disease symptom. One 
retrospective report documenting the clinical features of H5N1 in Vietnam found that 
diarrhea was more common in fatal than nonfatal H5N1 cases [23].  Viral RNA has also 
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been detected in rectal swabs of patients [28,29].  Our efforts to stain for viral antigen in 
mouse intestines were only successful when harsh antigen retrieval methods were used. 
This left the tissue damaged, and therefore images are not included here.  We are 
confident that these results are not false-positive staining artifacts, because negative 
controls did not stain for the viral antigen.  Instead, we think these results represent a 
technical limitation in the sensitivity of the immunohistochemistry procedure.  The 
technical difficulty in IHC staining in intestinal tissue is consistent with reports of human 
H5N1 infection in which IHC staining was negative, yet viral RNA was detected in the 
same tissues [24,25].   
 
Since the onset of the H5N1 outbreak, global efforts have been aimed at 
understanding this highly pathogenic virus. Attempts to elucidate the molecular 
mechanisms for viral pathogenesis have been pursued.  Among the findings are the single 
amino acid change in the RNA polymerase PB2 at position 627 and an amino acid 
change at position 66 of the PB1-F2 protein—both of which modulate virulence [30-32].  
The hemagglutinin protein also has been shown to be an important mediator of virulence 
in H5N1 viruses.  Increased cleavability of the receptor by ubiquitous proteases has been 
shown to correlate with increased virulence [30,32]. In addition, NS1 has been reported 
to play a role in the virulence of H5N1.  Single amino acid changes in NS1 at residues 42, 
92, and 149 have been found to increase the virulence of H5N1 [33,34,108].   
 
The PDZ motif of NS1 was previously found to modulate virulence of H5N1 in 
mice, yet the cellular pathway responsible for this affect was undetermined [71].  Our 
work helps bridge this understanding by defining one of the mechanisms by which the 
PDZ motif of NS1 is contributing to the pathogenicity of the virus.  We are the first to 
show that NS1 can interact with SAP-97 and that this interaction has functional 
consequence in disrupting epithelial barrier integrity. 
 
  In this study, our aim was to understand how the host and viral protein-protein 
interactions of NS1, through its PDZ-binding motif, may contribute to the disease 
phenotype of pulmonary edema and diarrhea.  Here, we characterize the interaction 
between NS1 and the adherens junction protein SAP-97.  SAP-97 function is crucial for 
adherens junction integrity, and therefore inhibiting this pathway can lead to loss of 
epithelial barrier function [85,88,89,92-95].   
 
Based on our data, we conclude that NS1 of H5N1 binds PDZ 2 of SAP-97.  The 
interaction between NS1 and SAP-97 is PDZ motif-dependent; NS1 with an altered PDZ 
motif (NS1-HuPDZ) and NS1 lacking the PDZ binding motif (NS1-ΔPDZ) are not able 
to bind SAP-97.  In virus-infected tissues, where there is evidence of disruption in the 
epithelial barriers, the normal distribution of SAP-97 is altered.  In NS1-WT-transfected 
cells, we demonstrated that the epithelia are delayed in forming cell-cell junctions, as 
evidenced by their inability to form resistant monolayers and high rates of paracellular 
flux.  SAP-97-depleted cells also display delays in junctional formation and have high 
paracellular flux rates.  This functional data clearly suggests that NS1 is able to inhibit 
the establishment of cell junctions through interacting with SAP-97.  Therefore, the 
interaction between NS1 and SAP-97 has a functional consequence in disrupting the 
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adherens junction, thus contributing to the disease severity of the virus.  The physical and 
functional interaction between NS1 and SAP-97 may help us understand one of 
mechanisms by which H5N1-infected tissues accumulate edema that leads to pulmonary 
edema in the lung and diarrhea in the intestines. 
 
I propose the following model to explain the mechanism by which NS1 acts on SAP-
97 to disrupt epithelial barrier integrity.  At the epithelial cell membrane, NS1 interacts 
with SAP-97 in a PDZ-dependent manner.  The binding of NS1 to PDZ 2 of SAP-97 
sequesters SAP-97, thus preventing it from participating in the maintenance of the 
adherens junction.  A loss of SAP-97 at the adherens junction soon leads to disruption in 
the integrity of the junctional complex and consequently a loss in the integrity of the 
epithelial barrier.  The subsequent compromise in the epithelial barrier function 
contributes to disease phenotypes seen in H5N1 infection: pulmonary edema in the lung 
and diarrhea in the intestines.   
 
 The interaction of NS1 of H5N1 and SAP-97 is the only interaction of NS1 with a 
host protein that has been investigated.  The individual interactions of NS1 with other 
host proteins have not been fully defined and the functionally of these interations merits 
future investigation.  These studies do not rule out the possibility that PDZ motif-
dependent interactions of NS1 with other proteins of the junctional complex or polarity 
proteins may contribute to the disease phenotype observed in these studies.  As these 
protein-protein interactions are studied the pathogenic mechanisms of the highly virulent 
H5N1 virus will be better understood.   
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